###begin article-title 0
###xml 10 18 10 18 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Frizzled</italic>
A Cryptic Frizzled Module in Cell Surface Collagen 18 Inhibits Wnt/beta-Catenin Signaling
###end article-title 0
###begin p 1
Conceived and designed the experiments: OM. Performed the experiments: OM DQ EL IH UT RH. Analyzed the data: OM DQ EL BC. Contributed reagents/materials/analysis tools: OM IH HE RH TP. Wrote the paper: OM BC.
###end p 1
###begin p 2
###xml 308 309 308 309 <underline xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">f</underline>
###xml 311 312 311 312 <underline xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">z</underline>
###xml 308 316 308 316 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><underline>f</underline>ri<underline>z</underline>zled</italic>
###xml 418 426 418 426 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">frizzled</italic>
###xml 885 886 882 883 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">r</sub>
###xml 1010 1018 1007 1015 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 1313 1318 1304 1309 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">c-myc</italic>
###xml 1625 1633 1613 1621 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">frizzled</italic>
###xml 1633 1634 1621 1622 <underline xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">c</underline>
###xml 1642 1643 1630 1631 <underline xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">r</underline>
###xml 1647 1648 1635 1636 <underline xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">d</underline>
###xml 612 617 <span type="species:ncbi:9606">human</span>
###xml 748 753 <span type="species:ncbi:9606">human</span>
###xml 1287 1298 <span type="species:ncbi:111938">gatekeepers</span>
Collagens contain cryptic polypeptide modules that regulate major cell functions, such as cell proliferation or death. Collagen XVIII (C18) exists as three amino terminal end variants with specific amino terminal polypeptide modules. We investigated the function of the variant 3 of C18 (V3C18) containing a frizzled module (FZC18), which carries structural identity with the extracellular cysteine-rich domain of the frizzled receptors. We show that V3C18 is a cell surface heparan sulfate proteoglycan, its topology being mediated by the FZC18 module. V3C18 mRNA was expressed at low levels in 21 normal adult human tissues. Its expression was up-regulated in fibrogenesis and in small well-differentiated liver tumors, but decreased in advanced human liver cancers. Low FZC18 immunostaining in liver cancer nodules correlated with markers of high Wnt/beta-catenin activity. V3C18 (Mr = 170 kD) was proteolytically processed into a cell surface FZC18-containing 50 kD glycoprotein precursor that bound Wnt3a in vitro through FZC18 and suppressed Wnt3a-induced stabilization of beta-catenin. Ectopic expression of either FZC18 (35 kD) or its 50 kD precursor inhibited Wnt/beta-catenin signaling in colorectal and liver cancer cell lines, thus downregulating major cell cycle checkpoint gatekeepers cyclin D1 and c-myc and reducing tumor cell growth. By contrast, full-length V3C18 was unable to inhibit Wnt signaling. In summary, we identified a cell-surface signaling pathway whereby FZC18 inhibits Wnt/beta-catenin signaling. The signal, encrypted within cell-surface C18, is released by enzymatic processing as an active frizzledcysteine-rich domain (CRD) that reduces cancer cell growth. Thus, extracellular matrix controls Wnt signaling through a collagen-embedded CRD behaving as a cell-surface sensor of proteolysis, conveying feedback cues to control cancer cell fate.
###end p 2
###begin title 3
Introduction
###end title 3
###begin p 4
###xml 373 376 373 376 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001878-Bornstein1">[1]</xref>
The cell surface matrix is a signaling platform integrating bidirectional cues between cells and extracellular matrix (ECM), which contains growth factors, proteases and bioactive polypeptides, thus controlling major signaling pathways. Cryptic bioactive polypeptides become functional by structural or conformational changes of parent ECM molecules, including proteolysis [1].
###end p 4
###begin p 5
###xml 21 24 21 24 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001878-Rehn1">[2]</xref>
###xml 26 29 26 29 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001878-Muragaki1">[3]</xref>
###xml 65 68 65 68 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001878-OReilly1">[4]</xref>
###xml 187 190 187 190 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001878-Muragaki1">[3]</xref>
###xml 192 195 192 195 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001878-Rehn2">[5]</xref>
###xml 399 402 399 402 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001878-Lietard1">[6]</xref>
###xml 404 407 404 407 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001878-Elamaa1">[7]</xref>
###xml 531 532 531 532 <underline xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">D</underline>
###xml 541 542 541 542 <underline xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">U</underline>
###xml 549 550 549 550 <underline xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">F</underline>
###xml 636 639 636 639 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001878-Saarela1">[8]</xref>
###xml 694 697 694 697 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001878-Musso1">[9]</xref>
###xml 753 757 753 757 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001878-Musso2">[10]</xref>
###xml 885 886 885 886 <underline xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">c</underline>
###xml 894 895 894 895 <underline xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">r</underline>
###xml 899 900 899 900 <underline xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">d</underline>
###xml 919 927 919 927 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">frizzled</italic>
###xml 951 952 951 952 <underline xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">s</underline>
###xml 960 961 960 961 <underline xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">f</underline>
###xml 960 968 960 968 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><underline>f</underline>rizzled</italic>
###xml 969 970 969 970 <underline xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">r</underline>
###xml 977 978 977 978 <underline xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</underline>
###xml 994 998 994 998 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001878-Xu1">[11]</xref>
Collagen XVIII (C18) [2], [3], the parent molecule of endostatin [4], is expressed as three distinct variants by two separate promoters and alternative splicing of one of the transcripts [3], [5]. Promoter #1 generates variant #1 (V1C18), which is a ubiquitous structural basement membrane component. Alternative splicing of transcripts from promoter #2 generates variants #2 (V2C18) and #3 (V3C18) [6], [7], which are secreted under the control of both liver-specific and ubiquitous transcription factors. V2C18 contains a 192-aa Domain of Unknown Function-959 (DUF-959) at its N-terminus, followed by sequences common to all variants [8]. V2C18 is secreted as a plasma protein by hepatocytes [9] and its expression decreases in advanced liver cancers [10]. V3C18 carries a 235-aa stretch with 10 conserved cysteines, bearing sequence and structural identities with the extracellular cysteine-rich domain (CRD) of the frizzled (FZ) receptors and the secreted frizzled-related proteins (SFRPs) [11]. Hence, we named this module FZC18.
###end p 5
###begin p 6
###xml 380 384 371 375 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001878-Clevers1">[12]</xref>
###xml 904 909 889 894 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">c-myc</italic>
###xml 909 913 894 898 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001878-Clevers1">[12]</xref>
###xml 944 948 929 933 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001878-Benhamouche1">[13]</xref>
In the Wnt/beta-catenin signaling pathway, interaction of 10 different FZ cell-surface receptors with at least 19 Wnts can be inhibited by a family of 5 SFRPs that bind to Wnts at the cell surface. In the absence of Wnt, beta-catenin is recruited into a destruction complex, phosphorylated at conserved N-terminal residues by GSK3beta, and thus tagged for proteasomal degradation [12]. In the nucleus, target genes of the pathway are repressed by co-repressor binding to T-cell factor (TCF) transcription factors. Wnt binding to FZ receptors blocks beta-catenin phosphorylation, which becomes resistant to proteasomal degradation. Consequently, beta-catenin accumulates both in the cytoplasm and the nucleus, displacing co-repressors from TCF and activating transcription of target genes that regulate the balance between proliferation and apoptosis, differentiation and metabolism, including cyclin D1, c-myc[12] and glutamine synthetase (GS) [13].
###end p 6
###begin p 7
###xml 234 238 228 232 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001878-Clevers1">[12]</xref>
###xml 298 302 292 296 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001878-Caldwell1">[14]</xref>
###xml 371 375 362 366 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001878-Suzuki1">[15]</xref>
###xml 501 505 489 493 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001878-LaurentPuig1">[16]</xref>
###xml 539 543 527 531 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001878-Shih1">[17]</xref>
###xml 47 52 <span type="species:ncbi:9606">human</span>
###xml 390 395 <span type="species:ncbi:9606">human</span>
Wnt/beta-catenin signaling can be activated in human cancers by oncogenic mutations or by epigenetic silencing of pathway components. Respectively, 85% and 10% of sporadic colorectal cancers (CRCs) have APC and beta-catenin mutations [12]. Epigenetic inactivation of SFRP genes occurs early in CRC [14] and restoring SFRP expression attenuates Wnt/beta-catenin signaling [15]. In 30-40% of human hepatocellular carcinomas (HCCs), activation of the pathway results from beta-catenin and axin mutations [16] or epigenetic silencing of SFRP1 [17].
###end p 7
###begin p 8
###xml 253 261 250 258 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
We investigated whether FZC18 could regulate Wnt/beta-catenin signaling. We show that V3C18 mRNA expression decreases in advanced HCCs. In addition, the N-terminus of the V3C18 is partially processed to a FZC18 precursor (V3Nter) which pulls down Wnt3a in vitro, suppresses Wnt/beta-catenin signaling and downstream gene expression, reduces tumor cell growth and increases cell death in CRC and HCC cell lines carrying activating beta-catenin mutations. The biological activity of FZC18 is cryptic within full-length C18, as it is activated by proteolytic release.
###end p 8
###begin title 9
Results
###end title 9
###begin title 10
Decreased expression of V3C18 in cancer cell lines and in advanced primary liver cancers
###end title 10
###begin p 11
###xml 116 125 116 125 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001878-g001">Figure 1B</xref>
###xml 369 378 369 378 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001878-g001">Figure 1C</xref>
###xml 594 598 594 598 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001878-Vallet1">[18]</xref>
###xml 679 688 679 688 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001878-g001">Figure 1C</xref>
###xml 40 45 <span type="species:ncbi:9606">human</span>
###xml 297 302 <span type="species:ncbi:9606">human</span>
###xml 421 426 <span type="species:ncbi:10090">mouse</span>
We analyzed the mRNA levels of V3C18 in human tissues by QRT-PCR (quantitative RT-PCR) using brain as a calibrator (Figure 1B). V3C18 showed the highest levels in kidney, followed by liver, placenta, lung, bone marrow and testis. The expression of V3C18 was 2 to 14 folds lower in cell lines from human HCC, CRC, breast cancer or embryonic kidney than in normal liver (Figure 1C). In addition, in the well-differentiated mouse hepatoma cell line mhAT3FS315, carrying a dominant negative form of the HNF3 transcription factor, inhibiting expression of genes controlling the hepatocyte phenotype [18], the expression of V3C18 mRNA was 22% of that in the parental cell line mhAT3F (Figure 1C).
###end p 11
###begin title 12
Reduced expression of FZC18 in advanced liver cancers and cell lines.
###end title 12
###begin p 13
###xml 677 679 675 677 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">32</sup>
###xml 226 231 <span type="species:ncbi:9606">human</span>
###xml 241 246 <span type="species:ncbi:9606">Human</span>
###xml 494 499 <span type="species:ncbi:9606">human</span>
(A) Schematic of V3C18 showing DUF-959, FZC18, Tsp-1 (thrombospondin-1) and ES (endostatin) modules. The thick horizontal yellow line below FZC18 indicates the probe used. (B-D) Relative mRNA expression of V3C18 by QRT-PCR in human tissues (Human Total RNA Master Panel, Clontech, USA) (B) and in cell lines (C). Assays were performed in triplicate with a coefficient of variation <10% and normalized to 18S. Brain (B) and liver (C) were used as calibrators. (D) Relative V3 mRNA expression in human liver samples. Small (</=2 cm), well-differentiated HCCs are compared to advanced HCCs. mRNA samples were blotted in triplicates onto nylon membranes and arrays hybridized with 32P-labeled cDNA under linear-range conditions. Densitometry readings were normalized with an 18S probe. Bar graphs show mean+/-SD. The Mann Whitney's "U" test was used. NS, non significant; NT, non tumor livers.
###end p 13
###begin p 14
###xml 103 107 103 107 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001878-Musso2">[10]</xref>
###xml 238 241 238 241 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001878-Elamaa1">[7]</xref>
###xml 466 475 466 475 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001878-g001">Figure 1D</xref>
###xml 736 739 728 731 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;07</sup>
###xml 772 776 764 768 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001878-Musso2">[10]</xref>
Low expression of V2C18 is associated with tumor progression and reduced disease-free survival in HCCs [10]. Although V2C18 and V3C18 share a common promoter, V3C18 is additionally regulated by alternative splicing of FZC18 to produce V2 [7]. Analysis of mRNA arrays from 122 frozen liver samples included normal livers from 19 subjects, 54 HCCs and 49 matching non tumor livers. V3C18 mRNA levels were higher in fibrotic and cirrhotic livers than in normal livers (Figure 1D), indicating that the expression of V3C18 increases during tissue remodeling. Small (</=2 cm) well-differentiated HCCs showed higher V3C18 mRNA levels than advanced HCCs. The mean+/-SD size of both groups was 1.3+/-0.38 cm and 6.5+/-4.6 cm, respectively (p = 3-07). As previously shown for V2C18 [10], these findings indicate that higher V3C18 mRNA expression may be associated with less aggressive tumors.
###end p 14
###begin title 15
###xml 46 52 46 52 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">V3Nter</italic>
V3C18 and its amino-terminal proteolyzed form V3Nter localize at the cell surface through the FZC18 module
###end title 15
###begin p 16
###xml 119 122 107 110 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001878-Elamaa1">[7]</xref>
###xml 312 318 300 306 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">V3Nter</italic>
###xml 320 329 308 317 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001878-g002">Figure 2A</xref>
###xml 346 352 334 340 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">V2Nter</italic>
###xml 400 409 388 397 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001878-g002">Figure 2A</xref>
###xml 0 5 <span type="species:ncbi:9606">Human</span>
Human embryonic kidney cells secrete a approximately45 kD amino-terminal fragment of V3C18 containing the FZC18 module [7]. These data led us to construct an expression vector including the natural signal peptide+DUF-959+FZC18 modules and 47 aa from the Tsp-1C18 domain common to all C18 variants that we called V3Nter (Figure 2A). As a control, V2Nter included the same sequences, but lacked FZC18 (Figure 2A).
###end p 16
###begin title 17
V3Nter localizes at the cell surface and inhibits Wnt/beta-catenin signaling and downstream protein expression.
###end title 17
###begin p 18
###xml 362 368 362 368 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">(red).</italic>
###xml 561 569 561 569 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0001878.s005">Movie S1</xref>
###xml 701 710 701 710 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0001878.s001">Figure S1</xref>
###xml 952 957 952 957 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">(red)</italic>
###xml 1097 1105 1097 1105 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">(arrow).</italic>
###xml 1145 1154 1145 1154 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">(arrows).</italic>
###xml 1267 1276 1267 1276 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">(arrows).</italic>
###xml 1462 1478 1459 1475 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SUPER8XTOPFLASH,</italic>
###xml 1545 1561 1542 1558 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SUPER8XFOPFLASH,</italic>
###xml 1735 1744 1732 1741 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0001878.s001">Figure S1</xref>
###xml 1903 1908 1900 1905 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">(top)</italic>
###xml 1924 1931 1921 1928 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">(right)</italic>
###xml 206 211 <span type="species:ncbi:10090">mouse</span>
###xml 337 343 <span type="species:ncbi:9986">rabbit</span>
###xml 793 798 <span type="species:ncbi:10090">mouse</span>
###xml 927 933 <span type="species:ncbi:9986">rabbit</span>
###xml 1009 1014 <span type="species:ncbi:10090">mouse</span>
(A) V3Nter and V2Nter expression vectors. Thick horizontal color lines indicate the antibodies used. Blue box, 47-aa stretch from the Tsp-1C18 module. (B1-C3) Confocal fluorescence microscopy of mhAT3FS315 mouse HCC cells transiently transfected with V3Nter (B1-B3) or V2Nter (C1-C3) cDNAs and probed with anti-DUF-959, followed by anti-rabbit TRITC-labeled IgG (red). Three out of 15 representative images acquired at 500-nm intervals on the vertical axis are shown. V3Nter (B1-B3) highlights intercellular spaces. V2Nter (C1-C3) is detected in the cytoplasm. Movie S1 shows a tridimensional reconstruction of V3Nter cell surface staining using the 15 acquired images (original magnification x1000). Figure S1, B-D shows confocal microscopy of V3FL and V2FL. (D-F) Fluorescence microscopy of mouse HCC cells transfected with either V3Nter (D and E) or V2Nter (F) cDNAs and incubated with either anti-DUF-959, followed by anti-rabbit TRITC-labeled IgG (red) (D and F) or anti-V5 epitope tag, followed by anti-mouse FITC-labeled IgG (E). (D) V3Nter outlines cell membranes and cell-cell boundaries (arrow). (E) V3Nter highlights the cell surface (arrows). (F) Secretion of V2Nter covers the cell surface and is detected on neighboring cells as dispersing red speckles (arrows). (G) Dose-dependent changes in CRT in response to increasing amounts of transiently transfected cDNA vectors. Reporter gene assays using a beta-catenin-TCF reporter driven by wild-type (SUPER8XTOPFLASH, white bars) or a negative control with mutated TCF binding sites (SUPER8XFOPFLASH, black bars). Results are means of three replicates from a representative experiment. Three independent experiments were performed. Error bars represent standard deviations. Figure S1, E and F shows changes in CRT in response to V3FL and V2FL. (H) Immunoblot of HCT116 cells transiently transfected and probed with the indicated cDNA vectors (top) and antibodies (right). Hsc70 is a loading standard.
###end p 18
###begin p 19
###xml 117 125 117 125 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001878-g002">Figure 2</xref>
###xml 185 193 185 193 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001878-g002">Figure 2</xref>
###xml 204 212 204 212 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0001878.s005">Movie S1</xref>
###xml 278 287 278 287 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001878-g002">Figure 2D</xref>
###xml 319 328 319 328 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001878-g002">Figure 2E</xref>
###xml 382 391 382 391 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001878-g002">Figure 2C</xref>
###xml 515 524 515 524 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001878-g002">Figure 2F</xref>
###xml 63 68 <span type="species:ncbi:10090">mouse</span>
Transient transfection of V3Nter or V2Nter cDNAs in mhAT3FS315 mouse hepatoma cells followed by immunocytochemistry (Figure 2, B-F) showed that V3Nter highlighted cell-cell boundaries (Figure 2, B, D and Movie S1) and cell membranes, particularly at sites of cell-cell contact (Figure 2D), as well as the cell surface (Figure 2E). By contrast, V2Nter was detected within the cells (Figure 2C). The surface of some of the cells was covered with V2Nter signal, with dispersing speckles detected on neighboring cells (Figure 2F), suggesting secretion.
###end p 19
###begin p 20
###xml 209 219 209 219 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0001878.s001">Figure S1B</xref>
###xml 327 337 327 337 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0001878.s001">Figure S1C</xref>
###xml 428 438 428 438 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0001878.s001">Figure S1D</xref>
###xml 523 533 523 533 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0001878.s001">Figure S1D</xref>
###xml 749 756 749 756 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 879 882 879 882 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001878-Musso1">[9]</xref>
###xml 884 888 884 888 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001878-Musso2">[10]</xref>
###xml 890 894 890 894 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001878-Musso3">[19]</xref>
###xml 988 996 988 996 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 1001 1008 1001 1008 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 1066 1072 1066 1072 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">(i.e.,</italic>
###xml 88 93 <span type="species:ncbi:10090">mouse</span>
Transient transfection of full-length V3C18 (V3FL) or full-length V2C18 (V2FL) cDNAs in mouse hepatoma cells followed by confocal immunofluorescence confirmed the above findings. V3FL outlined cell membranes (Figure S1B), whereas V2FL was detected within the cell. Cell membranes and intercellular boundaries showed no signal (Figure S1C). V2FL was also observed within large intracellular vacuoles resembling Golgi structures (Figure S1D). The cell surface showed fraying vesicles positive for V2FL, suggesting secretion (Figure S1D). Strong intracellular burden of V2Nter and V2FL in cells transiently expressing these proteins at high levels is consistent with our previous observation of intracellular signal for endogenous V2C18 in hepatocytes in vivo and is frequently observed in the case of other abundantly secreted plasma or ECM proteins such as albumin or fibronectin [9], [10], [19]. In addition, abundant intracellular material in some of the cells expressing V2C18 or V3C18 in vitro and in vivo suggested posttranslational maturation of these proteins (i.e., glycosylation, see below).
###end p 20
###begin title 21
V3Nter is a cryptic inhibitor of Wnt/beta-catenin signaling
###end title 21
###begin p 22
###xml 158 162 155 159 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001878-Suzuki1">[15]</xref>
###xml 495 504 472 481 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001878-g002">Figure 2G</xref>
###xml 528 537 505 514 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001878-g002">Figure 2G</xref>
###xml 555 565 532 542 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0001878.s001">Figure S1E</xref>
###xml 814 818 785 789 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001878-deLaCoste1">[20]</xref>
###xml 901 911 872 882 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0001878.s001">Figure S1F</xref>
###xml 727 732 <span type="species:ncbi:9606">human</span>
###xml 962 967 <span type="species:ncbi:10090">mouse</span>
SFRP1, SFRP2 and SFRP5 suppress beta-catenin-T-cell factor (TCF)-regulated transcription (CRT) from a TCF/LEF responsive reporter in the CRC cell line HCT116 [15]. We asked whether V3Nter and V3FL could inhibit Wnt/beta-catenin signaling in cell lines carrying activating beta-catenin mutations, HCT116 (beta-catenin DeltaS45) and HepG2 (HCC, beta-catenin Delta25-140) and used SFRP1 and SFRP5 as controls. Ectopic expression of SFRP1, SFRP5 or V3Nter suppressed CRT in a dose-dependent manner (Figure 2G). By contrast, V2Nter (Figure 2G), V2FL and V3FL (Figure S1E), increased CRT in HCT116, but not in HepG2 cells. The increase in CRT by V2Nter, V2FL and V3FL was also observed in other cell lines. In the well-characterized human HCC cell line Huh-7 (wild-type beta-catenin, baseline Wnt/beta-catenin signaling [20]) Wnt1, V2FL and V3FL increased CRT by more than 10 folds and V2Nter by 2.9 folds (Figure S1F). Similar results were obtained in the mhAT3FS315 mouse HCC cell line (not shown).
###end p 22
###begin p 23
###xml 117 120 117 120 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001878-Saarela1">[8]</xref>
###xml 559 577 559 577 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0001878.s001">Figure S1, A and G</xref>
###xml 814 824 814 824 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0001878.s001">Figure S1H</xref>
###xml 881 891 881 891 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0001878.s001">Figure S1H</xref>
###xml 990 1000 990 1000 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0001878.s001">Figure S1H</xref>
###xml 1055 1065 1055 1065 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0001878.s001">Figure S1B</xref>
###xml 1212 1216 1212 1216 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001878-Mikels1">[21]</xref>
###xml 1291 1300 1291 1300 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001878-g002">Figure 2A</xref>
###xml 1350 1353 1350 1353 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001878-Saarela1">[8]</xref>
###xml 1413 1428 1413 1428 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001878-g002">Figure 2G and S</xref>
###xml 308 313 <span type="species:ncbi:9606">human</span>
###xml 613 618 <span type="species:ncbi:10090">mouse</span>
C18 is a heparan sulfate proteoglycan (HSPG), which contains heparan sulfate attachment sites common to all variants [8]. Thus, endogenous V2C18 and V3C18, as well as their full-length and their amino-terminal constructs could be HSPGs. Consistently, immunoblotting of proteoglycan-enriched fractions from a human HCC with anti-FZC18, anti-DUF-959 and anti-Tsp-1C18 antibodies showed a high molecular weight smear typical of HSPGs. Important mobility shift and epitope unmasking were seen after digestion with heparin lyases, but not with chondroitinase ABC (Figure S1, A and G). Transfection of V2FL and V3FL in mouse hepatoma cells and detection of the most N-terminal (DUF-959) and C-terminal (endostatin) epitopes, as well as FZC18, confirmed the high molecular weight smear typical of HSPG for V2FL and V3FL (Figure S1H). Indeed, V2FL was detected in cell-conditioned medium (Figure S1H). By contrast, V3FL was detected at high levels in cell layers but not in the conditioned medium (Figure S1H), confirming its predominantly cell-surface location (Figure S1B). Therefore, V2FL-HSPG and V3FL-HSPG might locally increase Wnt concentration, thereby increasing CRT activity, as has been shown for other HSPGs [21]. In addition, V2Nter and V3Nter share a C-terminal 47 amino-acid stretch (Figure 2A) from the heparan sulfate attachment site of C18 [8], probably explaining the slight increase in CRT by V2Nter (Figure 2G and S1F).
###end p 23
###begin p 24
###xml 129 134 123 128 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">c-myc</italic>
###xml 166 175 160 169 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001878-g002">Figure 2H</xref>
###xml 317 322 308 313 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">c-myc</italic>
###xml 324 333 315 324 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001878-g002">Figure 2H</xref>
###xml 457 461 448 452 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001878-Lavoie1">[22]</xref>
###xml 594 604 585 595 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0001878.s001">Figure S1I</xref>
###xml 933 941 915 923 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">frizzled</italic>
Transient overexpression of V3Nter resulted in a reduced protein content of total beta-catenin, non phosphorylated beta-catenin, c-myc and cyclin D1 in HCT116 cells (Figure 2H). Consistently with data on CRT, V2FL and V3FL did not reduce the protein content of total and non phosphorylated beta-catenin, cyclin D1 or c-myc (Figure 2H). In addition, consistently with decreased cyclin D1 protein expression, reporter gene assays using the cyclin D1 promoter [22] upstream of luciferase cDNA confirmed that SFRP1, SFRP5 and V3Nter decreased cyclin D1 promoter activity in HCT116 and HepG2 cells (Figure S1I). Remarkably, overexpression of beta-catenin increased cyclin D1 promoter activity by 2.4 and 4.8 folds in HCT116 and HepG2 cell lines, respectively. Taken together, these data show that V3Nter can inhibit beta-catenin signaling in cancer cells carrying activating beta-catenin mutations and that the biological activity of the frizzled CRD is cryptic within full-length cell surface C18-HSPG.
###end p 24
###begin title 25
V3Nter inhibits tumor cell growth through increased cell death
###end title 25
###begin p 26
###xml 281 289 281 289 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001878-g003">Figure 3</xref>
###xml 913 922 889 898 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001878-g003">Figure 3C</xref>
###xml 1131 1140 1107 1116 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001878-g003">Figure 3D</xref>
###xml 1210 1219 1186 1195 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001878-g003">Figure 3E</xref>
###xml 1323 1331 1299 1307 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001878-g003">Figure 3</xref>
Based on these findings, we analyzed the effects of V3Nter on growth and death of tumor cells. Decreased colony formation occurred in HCT116 and HepG2 cells overexpressing V3Nter. Inhibition of clonogenesis by V3Nter, SFRP1 and SFRP5 were within the same range in both cell lines (Figure 3, A and B). beta-catenin induced a approximately30 % increase in colony formation in HCT116 and HepG2 cells, in consistency with data on cyclin D1 promoter activity, thus supporting the hypothesis that despite activating beta-catenin mutations, cells can still respond to stimuli inducing further increases in beta-catenin levels. HCT116 cells overexpressing SFRP1, SFRP5 or V3Nter showed chromatin condensation, nuclear fragmentation, numerous apoptotic bodies and an overall low cell density. By contrast, higher cell densities and rare apoptotic bodies were seen in cells expressing V2Nter, beta-catenin or vector alone (Figure 3C). Numbers of morphologically apoptotic Hoescht-stained cells and flow cytometry analysis of subG1 cells showed that V3Nter induced tumor cell death within the same range as SFRPs (25 to 35%) in HCT116 cells (Figure 3D). Similarly, SubG1 analysis on HepG2 cells showed 35-40% cell death (Figure 3E). As expected, vector alone and V2Nter showed baseline levels of cell death in HCT116 and HepG2 cells (Figure 3, D and E).
###end p 26
###begin title 27
V3Nter decreases colony formation and induces tumor cell death in HCT116 and HepG2 cells.
###end title 27
###begin p 28
###xml 721 722 717 718 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">4</sup>
HCT116 (A, C and D) and HepG2 (B, E) cells were transfected with cDNA vectors and selected for 14 d (A and B), 4 d (C and E) or 6-8 d (D) with G418. (A and B) After hematoxylin staining, colonies (seen as dark spots) were digitized using a video camera and counted with Scion Image (NIH). Histograms show colony formation efficiencies relative to cells transfected with empty vector. (C) Hoescht 33342-stained cells photographed at x200 magnification. Arrows indicate apoptotic cells. (D) Hoescht cell counts show mean+/-SD percent apoptotic cells out of triplicate 300-cell counts from 6-well plates (blindly at x200 magnification) at each time point. SubG1 shows mean+/-SD percent apoptotic cells out of triplicate 1x104 cells from 6-well plates assessed by flow cytometry at each time point. (E) Representative FL2-H histograms of HepG2 cells show percent SubG1 population.
###end p 28
###begin title 29
Amino terminal processing of V3Nter releases soluble FZC18
###end title 29
###begin p 30
###xml 39 40 39 40 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">r</sub>
###xml 50 59 50 59 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001878-g004">Figure 4A</xref>
###xml 114 123 102 111 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001878-g004">Figure 4B</xref>
###xml 318 327 306 315 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001878-g001">Figure 1C</xref>
###xml 394 403 382 391 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001878-g004">Figure 4C</xref>
###xml 424 425 412 413 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">r</sub>
###xml 545 554 533 542 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0001878.s001">Figure S1</xref>
###xml 676 679 664 667 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001878-Saarela1">[8]</xref>
###xml 766 770 754 758 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001878-Mikels1">[21]</xref>
###xml 224 229 <span type="species:ncbi:10090">mouse</span>
###xml 360 365 <span type="species:ncbi:9606">human</span>
HCT116 cell layers expressing V3Nter (Mr = 53 kD, Figure 4A) showed 80 kD and approximately30-40 kD polypeptides (Figure 4B). We thus studied the relevance of glycosylation and further proteolysis of bioactive V3Nter in the mouse HCC cell line mhAT3FS315. This cell line expresses endogenous V3C18 at very low levels (Figure 1C), which is not detected by anti-human FZC18 antibody (not shown). Figure 4C shows that V2Nter (Mr = 30 kD) and V3Nter migrated as high molecular weight smears typical of proteoglycans, consistently with data shown in Figure S1, G and H. This is explained by heparan sulfate attachment sites residing within the 47-aa stretch common to all variants [8] present in V2Nter and V3Nter constructs. Therefore, as has been shown for other HSPGs [21], V2Nter may locally increase Wnt concentration, resulting in a slight increase in CRT. However, the strong inhibition of Wnt/beta-catenin signaling by V3Nter could offset the slight increase in CRT by this 47 amino-acid stretch.
###end p 30
###begin title 31
Processing of V3Nter releases FZC18.
###end title 31
###begin p 32
###xml 24 30 24 30 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">(left)</italic>
###xml 42 49 42 49 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">(right)</italic>
###xml 287 293 287 293 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">(red).</italic>
###xml 565 574 541 550 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Asterisk,</italic>
###xml 680 683 644 647 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">(L)</italic>
###xml 707 711 671 675 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">(M).</italic>
###xml 798 802 738 742 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">(L).</italic>
###xml 826 830 766 770 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">(M),</italic>
###xml 1556 1568 1458 1470 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">(arrowheads)</italic>
###xml 1692 1702 1594 1604 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">(brackets)</italic>
###xml 1722 1731 1624 1633 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001878-g008">Figure 8G</xref>
(A) Schematic of V3Nter (left) and V2Nter (right) cDNA vectors. Horizontal color lines below each module indicate the antibodies used. (B) Immunoblot of protein extracts from HCT116 cells transfected with the indicated cDNAs, resolved in denaturing 7.5% PAGE-SDS and probed with anti-V5 (red). V3Nter shows approximately80 kD and approximately30-40 kD polypeptides. (C-E) Protein extracts from mhAT3FS315 cells transfected with the indicated cDNAs. Denaturing 5% (C) or 7.5% (D-E) PAGE-SDS gels. (C) V2Nter and V3Nter appear as smears typical of proteoglycans. (D) Asterisk, immunoglobulins from medium containing FCS. V2Nter shows a approximately50 kD polypeptide in cell layers (L) and conditioned medium (M). V3Nter shows approximately80 kD and approximately30-40 kD polypeptides in cell layers (L). By contrast, in medium (M), a 36 kD polypeptide predominates and the 80 kD form decreases in intensity. Note that 5 microg of protein was loaded for cell layers and 50 microg for conditioned media. The approximately80-kD V3Nter polypeptide is detected at much higher levels in cell layers than in media. In addition, V2Nter polypeptides are detected as a high molecular weight smear above the 80 kD marker in conditioned medium. (E) mhAT3FS315 cells transfected with V3Nter cDNA. Cell extracts incubated at 37degreesC for 2 hr with N-glycosidase, Sialidase A or buffer alone and probed with the indicated antibodies. Deglycosylation reveals polypeptides of approximately50 and 48 kD detected by anti-FZC18, anti-V5 and anti-DUF-959. A 36 kD polypeptide (arrowheads) is detected by anti-FZC18, anti-V5, but not by anti-DUF-959. [Anti-FZC18 detects nonspecific polypeptides between 30-40 kD (brackets), consistently with Figure 8G].
###end p 32
###begin p 33
###xml 137 146 125 134 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001878-g004">Figure 4D</xref>
###xml 429 438 405 414 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001878-g004">Figure 4D</xref>
###xml 501 511 477 487 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0001878.s001">Figure S1H</xref>
###xml 969 973 945 949 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001878-Sasaki1">[23]</xref>
###xml 1083 1086 1059 1062 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001878-Rehn1">[2]</xref>
###xml 1208 1217 1184 1193 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001878-g004">Figure 4D</xref>
Analysis of mhAT3FS315 cell layers confirmed the 80 kD and approximately30-40 kD FZC18-containing polypeptides detected in HCT116 cells (Figure 4D). Consistently with its predominant cell surface topology, the approximately80-kD V3Nter polypeptide was detected at much lower levels in cell conditioned media than in cell layers, even after loading a 10-fold higher amount of protein from conditioned media than from cell layers (Figure 4D). Similarly, V3FL was not detected in the conditioned medium (Figure S1H), suggesting that it is fully deposited within the cell surface matrix. Indeed, V3Nter is a noncollagenous domain, whereas V3FL contains both noncollagenous and collagenous domains. Thus, V3FL may be secreted as a triple helical homotrimer, being deposited in the pericellular matrix through supramolecular assemblies with other extracellular matrix molecules, such as laminins or cell surface heparan sulfates, which bind C18 through the endostatin domain [23]. In addition, V3FL may bind cell surface integrin receptors through RGD sequences in the collagenous domains [2]. By contrast, conditioned media showed a higher ratio of the 36 kD/80 kD FZC18-containing polypeptides than cell layers (Figure 4D, compare V3Nter in medium and in cell layers), suggesting that proteolytic processing releases a soluble FZC18 polypeptide.
###end p 33
###begin p 34
###xml 56 65 56 65 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001878-g004">Figure 4E</xref>
###xml 439 444 423 428 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">c-myc</italic>
###xml 450 460 434 444 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0001878.s002">Figure S2A</xref>
###xml 587 597 559 569 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0001878.s002">Figure S2B</xref>
###xml 650 651 622 623 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">r</sub>
###xml 884 894 832 842 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0001878.s002">Figure S2C</xref>
###xml 1112 1116 1060 1064 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001878-Benedetti1">[24]</xref>
Digestion of V3Nter with N-glycosidase and Sialidase A (Figure 4E) revealed approximately50 and 48 kD polypeptides containing FZC18, V5 and DUF-959 epitopes. In addition, a 36 kD polypeptide contained FZC18 and V5, but not DUF-959, suggesting that N-terminal processing of V3Nter results in the release of FZC18. To test whether FZC18 alone was active, we cloned the FZC18 module in frame with the IgKappa signal sequence and a C-terminal c-myc tag (Figure S2A). Expression in mhAT3FS315 cells revealed a soluble approximately35 kD N-glycosylated polypeptide in cell conditioned medium (Figure S2B). The close correspondence between the calculated (Mr = 31 kD) and the experimentally detected (approximately35 kD) molecular mass of FZC18 suggested that sialylation may not reside within FZC18. Consistently, Sialidase A digestion of V2Nter showed a approximately20 kD mobility shift (Figure S2C). Thus, sialic acid moieties in V3Nter may be responsible for FZC18 epitope masking. Consistently with the above findings, sialic acid is known to target glycoproteins to the extracellular side of the plasma membrane [24] and plays an important role in cell surface recognition and signaling.
###end p 34
###begin title 35
FZC18 suppresses Wnt/beta-catenin signaling
###end title 35
###begin p 36
###xml 109 117 106 114 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001878-g005">Figure 5</xref>
###xml 191 200 188 197 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001878-g005">Figure 5C</xref>
###xml 234 243 231 240 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001878-g005">Figure 5D</xref>
###xml 390 399 387 396 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001878-g005">Figure 5D</xref>
###xml 433 449 430 446 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001878-g002">Figures 2G and S</xref>
###xml 486 496 483 493 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0001878.s001">Figure S1I</xref>
FZC18 suppressed CRT and total and non-phosphorylated beta-catenin stabilization in a dose-dependent manner (Figure 5, A and B). In addition, FZC18 downregulated cyclin D1 promoter activity (Figure 5C) and decreased colony formation (Figure 5D) by 75% compared with cells expressing vector alone. In contrast, V2Nter induced a 21% increase in colony formation with respect to empty vector (Figure 5D), consistently with data on CRT (Figures 2G and S1F) and cyclin D1 promoter activity (Figure S1I).
###end p 36
###begin title 37
FZC18 suppresses Wnt/beta-catenin signaling and clonogenesis in cancer cells.
###end title 37
###begin p 38
###xml 70 86 67 83 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">(SUPER8XTOPFLASH</italic>
###xml 123 139 120 136 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">(SUPER8XFOPFLASH</italic>
###xml 496 504 493 501 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">(right).</italic>
(A) Reporter gene assays using a beta-catenin-TCF responsive reporter (SUPER8XTOPFLASH, white bars) and a negative control (SUPER8XFOPFLASH, black bars) in HCT116 cells. Dose-dependent decrease in CRT is detected in response to increasing amounts of transiently transfected FZC18 cDNA. Controls include SFRP1, SFRP5, V3Nter and V2Nter (250 ng cDNA). (B) Immunoblot of HCT116 cells transiently transfected with increasing amounts of FZC18 cDNA. The blots were probed with the indicated antibodies (right). Hsc70 is a loading standard. (C) Reporter gene assays using cyclin D1 promoter driving luciferase expression in transiently transfected HCT116 and HepG2 cells. Results are expressed relative to cells transfected with empty vector. (D) Colony formation assay in HCT116 cells transfected with FZC18 or V2Nter. Histograms show colony formation efficiencies.
###end p 38
###begin title 39
###xml 94 102 91 99 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
Ectopic FZC18 binds Wnt3a and suppresses Wnt3a-dependent activation of beta-catenin signaling in vitro
###end title 39
###begin p 40
###xml 151 159 151 159 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001878-g006">Figure 6</xref>
###xml 400 410 400 410 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0001878.s003">Figure S3A</xref>
###xml 499 508 499 508 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in silico</italic>
###xml 680 686 680 686 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">(Phyre</italic>
###xml 818 821 818 821 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;15</sup>
###xml 839 842 839 842 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;15</sup>
###xml 1319 1329 1319 1329 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0001878.s003">Figure S3B</xref>
###xml 1454 1458 1454 1458 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001878-Dann1">[25]</xref>
###xml 1680 1689 1680 1689 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001878-g006">Figure 6C</xref>
###xml 67 72 <span type="species:ncbi:10090">mouse</span>
###xml 736 741 <span type="species:ncbi:10090">mouse</span>
###xml 1492 1497 <span type="species:ncbi:10090">mouse</span>
###xml 1508 1513 <span type="species:ncbi:9606">human</span>
EBNA-293 cells were cotransfected with His-tagged Wnt3a and either mouse V3Nter or V2Nter expression vectors. Wnt3a pulled down V3Nter but not V2Nter (Figure 6, A and B), as shown by immunoblotting with anti-DUF-959 antibody. In addition, previous incubation of transfected cells with increasing concentrations of a 15-aa peptide derived from the CRD of FZC18 competed with FZC18 pull-down by Wnt3a (Figure S3A), suggesting that Wnt3a interacts directly with the CRD of FZC18. Then, we searched for in silico models predicting the 3D structure of the FZC18 CRD using threading algorithms that seek for template proteins with well-characterized crystal structures in PDB databases (Phyre www server). Two highly significant matches were mouse SFRP3 and FZ8, showing 32% and 22% identity, respectively. E-values were 1.4-15 for SFRP3 and 6.6-15 for FZ8, with an estimated precision of 100% for both models. Similar results were obtained by homology modeling using the www server HHpred, indicating 100% probability that the predicted 3D model of FZC18 CRD matches the templates SFRP3 and FZ8 (p = 0). Next, we looked at the localization of the competing peptide RH3 on the putative surface of the FZC18 CRD. Running the above models on Protein Explorer 2.79 showed that RH3 lies at the FZC18 CRD solvent-exposed surface (Figure S3B). In addition, the competing peptide lies adjacent to and partially overlaps residues involved in Wnt-mFZ8 CRD interactions [25]. Consistently, cotransfection of mouse Wnt3a and human FZC18 or V3Nter with a TCF-responsive reporter in the HEK293T and in the Huh-7 cell lines showed that FZC18 and V3Nter suppressed Wnt3a-induced CRT by more than 80% (Figure 6C). Taken together, these data show that FZC18 may interact with Wnt3a, suggesting that FZC18 may function as a SFRP-like bioactive polypeptide quenching at least Wnt3a in the tumor microenvironment.
###end p 40
###begin title 41
###xml 94 103 91 100 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro.</italic>
Ectopic FZC18 binds Wnt3a and suppresses Wnt3a-dependent activation of beta-catenin signaling in vitro.
###end title 41
###begin p 42
###xml 198 202 198 202 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">(IP)</italic>
###xml 281 282 281 282 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">H</sub>
###xml 290 291 290 291 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">L</sub>
###xml 405 422 402 419 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">(SUPER8XTOPFLASH)</italic>
###xml 445 463 442 460 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">(SUPER8XFOPFLASH).</italic>
###xml 148 153 <span type="species:ncbi:10090">mouse</span>
(A and B) Wnt3a pulls down V3Nter specifically via the FZC18 domain. EBNA-293 cells were cotransfected with V3Nter (A) or V2Nter (B) and His-tagged mouse Wnt3a. Cell lysates were immunoprecipitated (IP), resolved by 10% PAGE-SDS and immunoblotted with the indicated antibodies. IgGH and IgGL are immunoglobulin heavy and light chains. (C) Reporter gene assays using a beta-catenin-TCF responsive reporter (SUPER8XTOPFLASH) or a negative control (SUPER8XFOPFLASH). HEK293T or Huh-7 cells were cotransfected with Wnt3a and the indicated vectors. Results are means of three replicates from a representative experiment. Three independent experiments were performed. Error bars represent standard deviations.
###end p 42
###begin title 43
###xml 80 87 77 84 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
Negative correlation between FZC18 expression and beta-catenin pathway activity in vivo
###end title 43
###begin p 44
###xml 182 190 179 187 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001878-g007">Figure 7</xref>
###xml 381 385 378 382 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001878-ZucmanRossi1">[26]</xref>
###xml 426 435 423 432 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001878-g007">Figure 7A</xref>
###xml 515 524 512 521 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001878-g007">Figure 7B</xref>
###xml 526 530 523 527 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001878-Benhamouche1">[13]</xref>
Immunoreactivity for FZC18, beta-catenin and for the positive target of Wnt signaling glutamine synthetase (GS) was assessed on serial sections of normal, cirrhotic livers and HCCs (Figure 7). The intensity was semi-quantitatively recorded using a 5-point scale, from absent (-) to strong (++++), by comparing the staining in the tumor with adjacent non-tumor tissue, as described [26]. In normal liver, FZC18 was periportal (Figure 7A), contrasting with the well-characterized pericentral vein localization of GS (Figure 7B) [13], indicating that FZC18 epitopes are detected in zones of low beta-catenin pathway activation.
###end p 44
###begin title 45
###xml 70 78 67 75 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo.</italic>
FZC18 is negatively associated with Wnt/beta-catenin pathway activity in vivo.
###end title 45
###begin p 46
###xml 27 34 27 34 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">(brown)</italic>
###xml 144 151 141 148 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">(blue).</italic>
###xml 218 223 215 220 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">(PT).</italic>
###xml 262 267 259 264 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">(CV).</italic>
###xml 482 487 476 481 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">(NT),</italic>
###xml 558 562 552 556 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">(T).</italic>
###xml 583 584 577 578 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">T</italic>
###xml 598 600 592 594 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NT</italic>
###xml 652 668 643 659 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NT (thick arrow)</italic>
###xml 700 724 691 715 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">T (thin arrows) (inset).</italic>
###xml 852 864 843 855 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">(asterisks),</italic>
###xml 995 1003 986 994 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">(inset),</italic>
###xml 1069 1077 1057 1065 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">(inset),</italic>
###xml 1131 1140 1116 1125 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">(arrows).</italic>
Immunoperoxidase detection (brown) of FZC18, glutamine synthetase (GS) or beta-catenin in normal and tumor livers. Hematoxylin counter-staining (blue). (A-C) In normal liver, FZC18 (A) is detected around portal tracts (PT). No FZC18 is seen around central veins (CV). GS (B) is detected around CV. (C) Faint cell-membrane beta-catenin. (D-F) Contiguous sections of tumor liver tissue (TL #325) arising in a cirrhotic nodule. FZC18 (D) is detected in remaining non tumor hepatocytes (NT), compressed by the expansive growth of the tumor, but not in the tumor (T). GS (E) is strong in T and faint in NT. beta-catenin (F) is detected in cell membranes in NT (thick arrow) and in cytoplasm and nuclei in T (thin arrows) (inset). (G-L) Contiguous sections of tumor liver tissue (TL #04). Nodule-in-nodule showing faint FZC18 (G), but strong GS (H) staining (asterisks), surrounded by tumor tissue showing strong FZC18, but faint GS staining. (J and K) Higher magnification. (I) Strong FZC18 staining (inset), associated with membranous beta-catenin. (L) Mild FZC18 staining (inset), associated with cytoplasmic and nuclear beta-catenin (arrows).
###end p 46
###begin p 47
###xml 114 122 111 119 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001878-g007">Figure 7</xref>
###xml 264 272 258 266 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001878-g007">Figure 7</xref>
###xml 637 641 613 617 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001878-ZucmanRossi1">[26]</xref>
In HCCs, mild FZC18 signal was detected at sites where GS was strong and beta-catenin was cytoplasmic or nuclear (Figure 7, D-F). Conversely, strong FZC18 signal was detected at sites where GS staining was mild and beta-catenin was associated with cell membranes (Figure 7, G-L). Consistently, statistical analysis of data from 24 tumor nodules indicated that FZC18 was negatively correlated with GS (gamma = -0.42; p = 0.02; n = 24) and cytoplasmic beta-catenin staining (gamma = -0.47; p = 0.02; n = 23). Conversely, FZC18 was positively correlated with cell membrane beta-catenin staining (gamma = 0.67; p<0.001; n = 23). As expected [26], nuclear and cytoplasmic beta-catenin were positively correlated (gamma = 0.89; p<0.001; n = 23), as well as GS and nuclear (gamma = 0.74; p<0.001; n = 23) or cytoplasmic beta-catenin (gamma = 0.63; p<0.001; n = 23). These data suggest that the FZC18 module could inhibit Wnt/beta-catenin signaling in the tumor microenvironment.
###end p 47
###begin title 48
###xml 50 57 50 57 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
Proteolytic processing of V3C18 in cancer tissues in vivo
###end title 48
###begin p 49
###xml 150 158 150 158 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001878-g008">Figure 8</xref>
###xml 233 234 221 222 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">r</sub>
###xml 281 290 269 278 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001878-g008">Figure 8B</xref>
###xml 411 420 399 408 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001878-g008">Figure 8B</xref>
###xml 561 570 549 558 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001878-g008">Figure 8C</xref>
###xml 622 638 610 626 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001878-g008">Figure 8B and 8C</xref>
###xml 982 990 970 978 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">frizzled</italic>
Immunoblot analysis using anti-FZC18 antibody on whole protein extracts from histologically representative cryosections from normal and tumor livers (Figure 8, B and C) showed a approximately170 kD polypeptide consistent with V3FL (Mr = 178 kD) in 4/4 normal and 4/6 tumor livers (Figure 8B). In addition, a prominent polypeptide band was detected below the 74 kD marker in all tumors but not in normal livers (Figure 8B). Search for further proteolyzed forms in additional normal and tumor samples showed two polypeptides above the 50 kD marker in 7/7 tumors (Figure 8C). The tumor sample 01 (TL 01) was included both in Figure 8B and 8C, showing predominantly proteolyzed forms. These data show a higher ratio of proteolyzed over full-length forms in cancerous tissues and a higher ratio of full-length over proteolyzed forms in normal tissues. Thus, an important fraction of FZC18 detected by immunohistochemistry in HCCs corresponds to processed C18 polypeptides containing the frizzled CRD module, implying that the negative correlation between FZC18 staining and Wnt/beta-catenin activity in cancer tissues (see above) substantially corresponds to processed V3C18.
###end p 49
###begin title 50
###xml 0 7 0 7 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">In vivo</italic>
In vivo processing of the N-terminus of V3C18 releases a 50 kD FZC18 precursor.
###end title 50
###begin p 51
###xml 1053 1056 999 1002 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">g),</italic>
###xml 1372 1387 1306 1321 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">(V3Nter, arrow)</italic>
###xml 1837 1847 1771 1781 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">(brackets)</italic>
###xml 254 259 <span type="species:ncbi:9606">human</span>
###xml 749 754 <span type="species:ncbi:10090">mouse</span>
###xml 839 844 <span type="species:ncbi:9606">human</span>
(A) Schematic of V2 and V3 of C18 showing DUF-959, FZC18, Tsp-1C18 (thrombospondin-1) and ES (endostatin) modules. Thick horizontal color lines indicate the antibodies used. (B and C) Histologically representative 5-microm freeze-dried cryosections from human normal (NL) and tumor livers (TL) were scraped off slides with sterile scalpels, solubilized in 10% SDS buffer and dosed. Two hundred microg of whole protein extract was resolved by denaturing 5% (B) or 12% (C) PAGE-SDS, followed by immunoblot. NLs show a distinct approximately170 kD polypeptide (B). TLs show variable levels of the approximately170 kD polypeptide, a prominent polypeptide band below the 74 kD marker (B) and approximately50 to 60 kD bands (C). After membrane stripping, mouse monoclonal anti-alpha-tubulin antibody is used as a loading control. (D-G) A frozen human HCC tissue block (case TL 06, shown in B) was homogenized using a tissue grinder in non-denaturing buffer containing protease inhibitors at +4degreesC. Proteins were clarified by ultracentrifugation (130 000 g), fractionated by heparin-affinity chromatography and analyzed by denaturing 5% (D and F) or 12% (E and G) PAGE-SDS and immunoblot. (D) 170-kD V3C18 binds heparin with high affinity. (E) Non heparin-binding polypeptides from the N-terminus of C18: a approximately50 kD polypeptide is detected by the three antibodies (V3Nter, arrow). (F and G) Digestion of heparin-binding proteins with bacterial collagenase releases N-terminal noncollagenous polypeptides containing FZC18 and DUF-959 epitopes. Collagenase activity is inhibited by EDTA, suggesting that V3Nter can be released by a metalloprotease. Three identical sample sets were gel-migrated and blotted in parallel, then cut into 3 stripes before immunodetections. [Anti-FZC18 detects nonspecific polypeptides between 30-40 kD (brackets)].
###end p 51
###begin p 52
###xml 95 104 95 104 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001878-g008">Figure 8B</xref>
###xml 216 220 216 220 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001878-Sasaki1">[23]</xref>
###xml 370 379 334 343 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001878-g008">Figure 8D</xref>
###xml 427 436 391 400 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001878-g008">Figure 8E</xref>
###xml 547 556 511 520 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001878-g008">Figure 8E</xref>
###xml 607 616 571 580 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001878-g008">Figure 8F</xref>
###xml 695 704 659 668 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001878-g008">Figure 8G</xref>
###xml 863 872 815 824 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001878-g008">Figure 8G</xref>
###xml 925 926 877 878 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">r</sub>
###xml 1078 1087 1030 1039 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001878-g008">Figure 8G</xref>
###xml 1127 1135 1079 1087 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 1299 1306 1251 1258 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
Protein homogenates from the HCC case TL 06 containing both full-length and proteolyzed forms (Figure 8B) were fractionated by heparin-affinity chromatography, because C18 binds heparin through C-terminal endostatin [23]. Heparin-binding full-length (approximately170 kD) and partially processed FZC18-containing polypeptides (approximately130 and approximately120 kD) (Figure 8D) were separated from non heparin-binding ones (Figure 8E). Among non heparin-binding proteins, a 50 kD polypeptide contained the FZC18, Tsp-1C18 and DUF-959 epitopes (Figure 8E). Digestion of endogenous V3C18 with collagenase (Figure 8F) released 80 kD and 50 kD polypeptides, the reaction being inhibited by EDTA (Figure 8G), indicating that these polypeptides can be released by a metalloprotease. Interestingly, a approximately26 kD polypeptide was detected by anti-DUF-959 only (Figure 8G). Its molecular weight is consistent with DUF-959 (Mr = 20 kD). In addition, the anti-Tsp-1C18 antibody detected three collagenase-resistant polypeptides (48; 44 and 32 kD), but not the 50 kD polypeptide (Figure 8G). Thus, the 50 kD polypeptide released in vitro by collagenase digestion of endogenous C18 is a partially processed form of V3C18 containing the FZC18 and DUF-959 modules, which confirms the existence of V3Nter in vivo.
###end p 52
###begin p 53
###xml 122 125 122 125 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001878-Musso1">[9]</xref>
###xml 189 198 189 198 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001878-g008">Figure 8B</xref>
###xml 269 285 269 285 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001878-g007">Figures 7A and S</xref>
###xml 424 432 421 429 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001878-g007">Figure 7</xref>
###xml 650 659 644 653 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001878-g004">Figure 4E</xref>
###xml 107 112 <span type="species:ncbi:9606">human</span>
We previously showed that full-length V2C18 is an abundant plasma protein secreted by the liver in healthy human subjects [9]. Consistently, unprocessed V3C18 was detected in normal liver (Figure 8B), suggesting that the periportal signal seen by immunohistochemistry (Figures 7A and S4A) corresponds mainly to V3FL. Since V3FL is predominantly detected in liver zones characterized by low Wnt/beta-catenin activity levels (Figure 7, A-C), it would be tempting to speculate that the expression of V3C18 could be negatively regulated by Wnt/beta-catenin signaling. However, we also showed that some of the FZC18 epitopes may be masked by sialic acid (Figure 4E). Therefore, antibody-based analysis of V3C18 does not necessarily reflect expression, as detection can be influenced by post-translational processing.
###end p 53
###begin title 54
###xml 43 50 43 50 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
Differential topology of FZC18 and DUF-959 in vivo
###end title 54
###begin p 55
###xml 60 69 60 69 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro,</italic>
###xml 148 158 148 158 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0001878.s004">Figure S4B</xref>
###xml 257 267 257 267 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0001878.s004">Figure S4D</xref>
###xml 377 385 377 385 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0001878.s006">Movie S2</xref>
###xml 515 524 515 524 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001878-g008">Figure 8B</xref>
###xml 112 117 <span type="species:ncbi:9606">human</span>
###xml 346 351 <span type="species:ncbi:9606">human</span>
Consistently with pericellular matrix localization of FZC18 in vitro, FZC18 highlighted intercellular spaces in human primary liver cancer tissues (Figure S4B) and was detected either at the surface of tumor cells or as supranuclear intracellular material (Figure S4D), as shown by a tridimensional reconstruction of FZC18 at the cell surface in human liver cancer case TL 03 (Movie S2). In this case, cell surface signal likely corresponds to fully proteolyzed FZC18-containing V3C18 polypeptides, as was shown in Figure 8B.
###end p 55
###begin p 56
###xml 7 17 7 17 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0001878.s004">Figure S4D</xref>
###xml 30 40 30 40 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0001878.s004">Figure S4E</xref>
###xml 290 294 290 294 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">eg.,</italic>
###xml 294 304 294 304 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001878-g004">Figures 4A</xref>
###xml 309 311 309 311 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001878-g008">8A</xref>
###xml 441 451 441 451 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0001878.s004">Figure S4D</xref>
###xml 471 481 471 481 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0001878.s004">Figure S4E</xref>
V3C18 (Figure S4D) and V2C18 (Figure S4E) showed a highly contrasting topology in contiguous tissue sections from liver cancer, V3C18 highlighting individual cells and V2C18 outlining tumor sinusoids. Anti-DUF-959 antibody detects both V3Nter and V3FL, as well as both V2Nter and V2FL (see eg.,Figures 4A and 8A), whereas anti-FZC18 detects FZC18, V3Nter and V3FL. Bearing this in mind, the highly different signal obtained with anti-FZC18 (Figure S4D) and anti-DUF-959 (Figure S4E) antibodies in contiguous sections of liver cancer was surprising. Several lines of evidence explain these data.
###end p 56
###begin p 57
###xml 63 72 63 72 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001878-g001">Figure 1B</xref>
###xml 290 292 282 284 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;8</sup>
###xml 398 401 390 393 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001878-Muragaki1">[3]</xref>
###xml 403 406 395 398 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001878-Elamaa1">[7]</xref>
###xml 408 412 400 404 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001878-Rehn3">[27]</xref>
###xml 24 29 <span type="species:ncbi:9606">human</span>
First, using the normal human total mRNA master panel shown in Figure 1B, we compared the mRNA expression levels of V2C18 and V3C18 by QRT-PCR. The expression of V3C18 was several folds lower than that of V2C18 mRNAs. Mean DeltaCT were 12.2+/-1.6 for V2C18 and 16.1+/-1.3 for V3C18 (p = 4.5-8, Mann-Whitney's U Test), consistently with previous data showing that V3 is expressed at very low levels [3], [7], [27].
###end p 57
###begin p 58
###xml 129 131 129 131 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">32</sup>
###xml 349 352 349 352 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001878-Muragaki1">[3]</xref>
###xml 354 357 354 357 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001878-Elamaa1">[7]</xref>
###xml 359 363 359 363 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001878-Rehn3">[27]</xref>
###xml 571 589 571 589 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0001878.s004">Figure S4, D and E</xref>
###xml 674 683 674 683 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001878-g004">Figure 4E</xref>
###xml 845 854 845 854 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001878-g004">Figures 4</xref>
###xml 859 861 859 861 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0001878.s002">S2</xref>
###xml 964 972 964 972 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001878-g008">Figure 8</xref>
###xml 1008 1018 1008 1018 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0001878.s004">Figures S4</xref>
Second, we confirmed these data by probing a panel of 8 normal, 12 cancer and 7 inflammatory liver tissues by Northern blot with 32P-labeled cDNA probes, revealing film exposure times several folds longer for V3C18 than for V2C18 to detect signal (data not shown). Thus, given the much higher expression levels of V2C18 than of V3C18 in all tissues [3], [7], [27], immunohistochemical detection of endogenous C18 with anti-DUF-959 antibody reveals the quantitatively predominating V2C18 signal, whereas anti-FZC18 antibody detects only V3C18. Consistently, comparison of Figure S4, D and E, shows higher signal intensity with anti-DUF-959 antibody. In addition, as shown in Figure 4E, antibody-based analysis of V3C18 strictly reveals unmasked FZC18 epitopes. As unmasking of FZC18 can be achieved by clipping off the sialylated DUF-959 module (Figures 4 and S2) and immunostaining in tumors reveals mainly proteolytically processed FZC18-containing polypeptides (Figure 8), the striking differences between Figures S4, D and E denote differential topology of FZC18 and DUF-959 modules, respectively.
###end p 58
###begin title 59
Discussion
###end title 59
###begin p 60
###xml 264 272 258 266 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">frizzled</italic>
###xml 445 453 439 447 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 152 157 <span type="species:ncbi:9606">human</span>
###xml 223 228 <span type="species:ncbi:9606">human</span>
We identified FZC18 as a novel extracellular inhibitor of Wnt/beta-catenin signaling. FZC18 decreases tumor cell growth through increased cell death in human cancer cell lines carrying activating beta-catenin mutations. In human liver cancers, C18 is processed to frizzled CRD-containing polypeptides and FZC18 immune reactivity negatively correlates with active Wnt signaling. Moreover, FZC18 localizes at the cell surface and pulls down Wnt3a in vitro, suppressing Wnt-dependent activation of beta-catenin signaling. Furthermore, proteolytic processing regulates the biological activity of FZC18, as full-length C18 does not suppress beta-catenin regulated gene expression.
###end p 60
###begin title 61
FZC18 inhibits Wnt signaling in cancer cells carrying activating beta-catenin mutations
###end title 61
###begin p 62
###xml 61 66 58 63 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CCND1</italic>
###xml 340 344 326 330 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001878-Bafico1">[28]</xref>
###xml 393 397 379 383 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001878-Suzuki1">[15]</xref>
###xml 577 582 560 565 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CCND1</italic>
###xml 805 809 781 785 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001878-Suzuki1">[15]</xref>
We show that exogenous wild-type beta-catenin increases CRT, CCND1 promoter activity and tumor cell survival in HCT116 and in HepG2 cells carrying heterozygous beta-catenin DeltaS45 and Delta25-140, respectively, thus lacking key phosphorylable residues in one of the alleles. Recent reports showed that HCT116 cells express canonical Wnts [28] and respond to exogenous Wnt1 by increasing CRT [15]. Thus, oncogenic beta-catenin mutations do not saturate TCF-dependent transcription in cancer cells. Consistently, in HCT116 and HepG2 cells, SFRP1, SFRP5 and FZC18 decrease CRT, CCND1 promoter activity and cell survival and thereby induce cell death. In agreement with our data, overexpression of SFRP1, SFRP2 and SFRP5 in HCT116 and SW480 CCR cells destabilize ectopically expressed beta-catenin DeltaS45 [15]. Taken together, these data indicate that FZC18 destabilizes beta-catenin in cells carrying heterozygous beta-catenin activating mutations.
###end p 62
###begin title 63
FZC18 reduces tumor cell growth
###end title 63
###begin p 64
###xml 153 159 150 156 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">c-myc.</italic>
###xml 418 423 391 396 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">c-myc</italic>
###xml 449 457 422 430 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 551 555 521 525 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001878-Suzuki1">[15]</xref>
###xml 629 633 599 603 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001878-Melkonyan1">[29]</xref>
###xml 711 715 681 685 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001878-Zi1">[30]</xref>
In CRC and HCC cell lines, FZC18 decreases the protein levels of total and non-phosphorylated beta-catenin and downstream targets, such as cyclin D1 and c-myc. These findings are associated with approximately60% to 70% reduction of tumor cell growth and approximately25% induction of cell death. These data are consistent with the fact that SFRP1, SFRP2 and SFRP5 suppress Wnt-dependent transcription by 60%, decrease c-myc mRNA expression, inhibit in vitro tumor growth and induce cell death in CRC cells carrying oncogenic mutations of beta-catenin [15]. Similarly, SFRP1 sensitizes breast cancer cells to proapoptotic stimuli [29] and SFRP3 suppresses tumor growth and cell invasion in prostate cancer cells [30].
###end p 64
###begin p 65
###xml 99 103 96 100 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001878-Chen1">[31]</xref>
###xml 193 197 190 194 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001878-Orford1">[32]</xref>
###xml 328 332 325 329 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001878-He1">[33]</xref>
###xml 334 338 331 335 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001878-You1">[34]</xref>
###xml 363 367 357 361 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001878-vandeWetering1">[35]</xref>
###xml 392 396 386 390 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001878-Chien1">[36]</xref>
Wnt-induced beta-catenin stabilization is an important survival signal which regulates homeostasis [31] and increases the threshold for contact inhibition and anchorage-independent cell growth [32]. As a result, reduction in tumor cell growth can be achieved by either extracellular quenching of Wnts with monoclonal antibodies [33], [34], beta-catenin knockdown [35] or restoring normal APC [36].
###end p 65
###begin p 66
###xml 16 21 16 21 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">c-myc</italic>
###xml 132 137 132 137 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">c-myc</italic>
###xml 171 175 171 175 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001878-You2">[37]</xref>
###xml 217 221 217 221 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001878-King1">[38]</xref>
###xml 232 237 232 237 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">c-myc</italic>
###xml 274 278 271 275 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001878-He2">[39]</xref>
###xml 337 341 331 335 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001878-Prange1">[40]</xref>
###xml 343 347 337 341 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001878-Colnot1">[41]</xref>
###xml 515 519 506 510 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001878-Tetsu1">[42]</xref>
###xml 558 562 549 553 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001878-Colnot1">[41]</xref>
###xml 723 727 711 715 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001878-Chien1">[36]</xref>
###xml 863 867 851 855 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001878-DeAlmeida1">[43]</xref>
FZC18 turns off c-myc in CRC cells, which may explain the induction of cell death. Indeed, Wnt signaling disables the checkpoint of c-myc-induced apoptosis in tumor cells [37], thus enhancing its prooncogenic effects [38]. Although c-myc is a target of beta-catenin in CRCs [39], its link with beta-catenin in HCCs remains controversial [40], [41]. In addition, FZC18 turns off cyclin D1 in CRC and HCC cancer cell lines. Cyclin D1 is a downstream effector of beta-catenin, promoting S-phase entry and tumor growth [42] and is frequently upregulated in HCCs [41]. The common theme in these approaches is the inhibition of the Wnt/beta-catenin pathway at different levels, providing a rationale for therapeutic intervention [36]. Particularly, inhibiting Wnt-FZ interaction at the cell surface was recently indicated as a viable strategy for anti-cancer treatment [43].
###end p 66
###begin title 67
###xml 26 34 26 34 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
Ectopic FZC18 binds Wnt3a in vitro
###end title 67
###begin p 68
###xml 58 66 58 66 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 504 508 504 508 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001878-Dann1">[25]</xref>
###xml 730 733 730 733 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">via</italic>
###xml 800 804 800 804 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001878-Bafico2">[44]</xref>
###xml 140 145 <span type="species:ncbi:9606">human</span>
We show that ectopically expressed Wnt3a pulls down FZC18 in vitro and that FZC18 suppresses Wnt3a-dependent activation of Wnt signaling in human cancer and embryonic kidney cells. Additionally, homology modeling shows 100% probability that the FZC18 CRD structure matches FZ8 and SFRP3 CRDs. Moreover, a peptide lying at the solvent-exposed surface of FZC18 CRD competes with the FZC18-Wnt3a interaction. This peptide partially overlaps residues previously shown to be essential to Wnt-FZ8 interactions [25]. Taken together, these data suggest that both partners could be associated at the cell surface and favor the hypothesis of Wnt quenching by FZC18. Alternatively, the interaction of FZC18 with the cell surface could occur via heterodimerization with FZ receptors, as has been shown for SFRPs [44] or through as yet unidentified receptors.
###end p 68
###begin title 69
###xml 70 77 67 74 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
FZC18 is negatively associated with Wnt/beta-catenin pathway activity in vivo
###end title 69
###begin p 70
###xml 257 261 251 255 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001878-Benhamouche1">[13]</xref>
###xml 393 401 387 395 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">frizzled</italic>
###xml 912 916 897 901 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001878-ZucmanRossi1">[26]</xref>
###xml 1132 1136 1114 1118 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001878-Loeppen1">[45]</xref>
###xml 1292 1296 1274 1278 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001878-Kovacevic1">[46]</xref>
###xml 225 229 <span type="species:ncbi:10090">mice</span>
In liver cancers, FZC18 immunostaining negatively correlates with Wnt/beta-catenin signaling and with the protein expression of the beta-catenin-regulated gene GS, consistently with the suppression of GS synthesis by DKK1 in mice carrying an APC disruption [13]. Immunohistochemistry with the anti-FZC18 antibody cannot distinguish between V3FL and processed V3C18 polypeptides containing the frizzled CRD. However, immunoblot analysis showed that V3C18 is predominantly processed in liver cancers, yielding the FZC18-containing polypeptide V3Nter, which inhibits Wnt/beta-catenin signaling. In addition, small, well-differentiated liver cancers express higher levels of V3C18 mRNA than large, less differentiated ones. Taken together, these results suggest that FZC18 can downregulate beta-catenin activation and expression of downstream genes, such as GS, a marker of activating beta-catenin mutations in HCCs [26]. Consistently, in chemically-induced carcinogenesis in rodents, GS (+) HCC foci grow faster than GS (-) ones and the GS (+) phenotype is associated with larger tumors, beta-catenin mutations and decreased apoptosis [45]. As glutamine is critical for the growth of highly proliferating cells, supporting protein and nucleotide synthesis and providing a major source of energy [46], GS could make the cell independent of glutamine supply, conferring a growth advantage.
###end p 70
###begin title 71
Bioactive FZC18 is encrypted within and released from V3C18
###end title 71
###begin p 72
###xml 192 199 192 199 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">V3Nter.</italic>
###xml 503 508 503 508 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">e.g.,</italic>
###xml 681 685 681 685 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001878-Overall1">[47]</xref>
The N-terminus of V3C18 undergoes stepwise proteolytic processing, involving release of a 50 kD biologically active precursor consisting of DUF-959, FZC18 and part of Tsp-1C18, that we called V3Nter. Release of V3Nter from endogenous V3C18 was inhibited by EDTA, suggesting that a metalloprotease (MMP) may be involved in decrypting FZC18 biological activity. MMPs are major players of ECM proteolysis at the cell surface in tumor invasion and metastasis, exposing and activating cryptic epitopes from, e.g., laminins, enhancing cell migration or from plasminogen, inhibiting angiogenesis. Thus, MMPs precisely control cell function and are therefore viewed as signaling molecules [47].
###end p 72
###begin p 73
###xml 80 83 80 83 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001878-Muragaki1">[3]</xref>
###xml 423 427 399 403 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001878-Mikels1">[21]</xref>
###xml 583 587 559 563 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001878-Hausmann1">[48]</xref>
###xml 694 698 670 674 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001878-Michineau1">[49]</xref>
###xml 757 760 733 736 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001878-Elamaa1">[7]</xref>
V3Nter is N-glycosylated, consistently with previous bioinformatics predictions [3]. Remarkably, sialylation masks some of the epitopes detected by the anti-FZC18 antibody because the approximately50; approximately48 and 36 kD polypeptides are only detected after Sialidase A digestion. Excision of DUF-959 from this precursor releases a FZC18-containing 36 kD N-glycosylated polypeptide. Wnts and SFRPs are N-glycosylated [21]. Glycosylation may be involved in apical cell-surface sorting and secretion of Wnts bound to lipoprotein particles, thus facilitating long-range signaling [48]. In addition, both N-glycosylation and sialylation may participate with disulfide bonding in dimerization [49]. Moreover, DUF-959 contains a conserved coiled-coil motif [7], which may be involved in oligomerization. Thus, glycans and conserved motifs may regulate the release of soluble and active FZC18.
###end p 73
###begin p 74
###xml 51 59 51 59 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">frizzled</italic>
###xml 149 157 149 157 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">frizzled</italic>
###xml 401 404 401 404 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001878-Saarela1">[8]</xref>
###xml 462 469 462 469 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 474 482 474 482 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 638 642 638 642 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001878-Mikels1">[21]</xref>
###xml 727 735 727 735 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">frizzled</italic>
###xml 821 829 821 829 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">frizzled</italic>
###xml 326 331 <span type="species:ncbi:9606">Human</span>
In summary, we show that C18 contains a functional frizzled CRD that we named FZC18. The biological activity of FZC18 is cryptic because full-length frizzled CRD-containing C18 is unable to inhibit Wnt signaling. Rather, full-length C18 may activate Wnt signaling regardless of the FZC18 module, as V2FL potently induces CRT. Human V1C18 is a HSPG and its HS attachment sites are not variant-specific [8]. Consistently, we show that V3C18 is a cell surface HSPG in vivo and in vitro. HS enhance Wnt signaling by raising local concentrations of Wnts at the cell surface, possibly promoting Wnt interaction with the FZ-LRP receptor complex [21]. Taken together, these data show for the first time a collagen containing a cryptic frizzled CRD, which can be released and activated by proteolysis. Moreover, the expression of frizzled CRD-containing C18 increases during fibrogenesis and in small, well-differentiated cancers with a favorable outcome.
###end p 74
###begin title 75
Materials and Methods
###end title 75
###begin title 76
Cell culture, tissue samples and mRNA expression analysis
###end title 76
###begin p 77
###xml 141 145 141 145 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001878-deLaCoste1">[20]</xref>
###xml 154 158 154 158 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001878-Gripon1">[50]</xref>
###xml 179 183 179 183 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001878-LeJossic1">[51]</xref>
###xml 235 239 235 239 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001878-Vallet1">[18]</xref>
###xml 409 413 409 413 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001878-Musso2">[10]</xref>
###xml 576 578 576 578 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">32</sup>
###xml 643 647 643 647 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001878-Musso2">[10]</xref>
###xml 0 5 <span type="species:ncbi:9606">Human</span>
###xml 100 105 <span type="species:ncbi:9606">Human</span>
###xml 192 197 <span type="species:ncbi:10090">mouse</span>
###xml 352 357 <span type="species:ncbi:9606">Human</span>
Human CRC cell lines HCT116, HT29 and Caco-2 were cultured in McCoy's 5A plus 10% FCS (Invitrogen). Human HCC cell lines HepG2, Huh-6, Huh-7 [20], HepaRG [50], BC1, BC2 and B16A2 [51] and the mouse HCC cell lines mhAT3F and mhAT3FS315 [18], were cultured as described. MCF-7, HEK293T and 293EBNA cells were cultured in DMEM (Invitrogen), plus 10% FCS. Human tissue samples and mRNA were obtained as described [10], complying with the guidelines of the National Steering Committee of HCC (INSERM, Paris). Relative mRNA expression was assessed using mRNA arrays hybridized with 32P-labelled cDNAs normalized to 18S under linear-range conditions [10] or by QRT-PCR using SYBR Green PCR Master Mix (Applied Biosystems) and the ABI Prism 7000 (Perkin Elmer). Expression was normalized to 18S and to a calibrator. Primers were designed with Primer 3 on the www. Sequences and conditions are available on request.
###end p 77
###begin title 78
cDNA clones
###end title 78
###begin p 79
###xml 47 50 47 50 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001878-Elamaa1">[7]</xref>
###xml 389 392 385 388 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">myc</italic>
###xml 616 620 612 616 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001878-Suzuki1">[15]</xref>
###xml 683 687 679 683 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001878-Veeman1">[52]</xref>
###xml 760 764 752 756 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001878-Lavoie1">[22]</xref>
###xml 818 823 810 815 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">hRluc</italic>
###xml 894 898 883 887 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001878-Hsu1">[53]</xref>
###xml 52 57 <span type="species:ncbi:9606">Human</span>
###xml 136 141 <span type="species:ncbi:10090">Mouse</span>
###xml 197 202 <span type="species:ncbi:9606">Human</span>
###xml 398 403 <span type="species:ncbi:10090">Mouse</span>
Full-length V2 and V3 C18 cDNAs were described [7]. Human V2Nter and V3Nter cDNAs were PCR-cloned in frame with a V5 tag into pcDNA3.1. Mouse V2Nter and V3Nter were cloned into pREP7 (Invitrogen). Human FZC18 was PCR-cloned in pCRII (Invitrogen) using V3Nter as a template, excised with EcoRI and cloned into pSecTag2 (Invitrogen) in frame with an IgKappa signal sequence and a C-terminal myc tag. Mouse Wnt1 (pV101, from R. Nusse) and Wnt3a (in pBSII KS+, from J. Kitajewski) cDNAs were transferred to pcDNA 3.1 (Invitrogen) in frame with a C-terminal poly-His tag. SFRP1 and 5 in pcDNA3.1/HisC were from S. Baylin [15]. Super8XTOP- and Super8XFOP-FLASH reporters were from R. Moon [52]. The Cyclin D1 promoter reporter D1Delta-944pXP2 was from J. Pouyssegur [22]. The normalization Renilla luciferase vector pGL4.70[hRluc] was from Promega. Wild-type beta-catenin cDNA was from R. Grosschedl [53]. All cDNAs were checked by automatic sequencing (Sequencing Facility, Rennes Hospital, France).
###end p 79
###begin title 80
Reporter assays
###end title 80
###begin p 81
###xml 11 12 11 12 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">4</sup>
###xml 274 279 274 279 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">hRluc</italic>
Cells (5x104/well) were transfected on 24-well plates with Lipofectamine Plus (Invitrogen). cDNA was normalized to 250 ng with the appropriate empty vectors. Super8XTOP/FOP Flash reporters (15 ng each) or Cyclin D1 promoter reporter (100 ng) were cotransfected with pGL4.70[hRluc] expressing Renilla luciferase. After 48 h, luciferase activity was measured in a scintillation counter (LS6500, Beckman) using the Dual Luciferase Reporter Assay System (Promega).
###end p 81
###begin title 82
Antibodies and immunological methods
###end title 82
###begin p 83
###xml 53 56 53 56 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001878-Saarela1">[8]</xref>
###xml 64 67 64 67 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001878-Elamaa1">[7]</xref>
###xml 83 87 83 87 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001878-Rehn4">[54]</xref>
###xml 208 213 208 213 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">c-myc</italic>
###xml 305 308 299 302 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">myc</italic>
###xml 697 700 691 694 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001878-Musso1">[9]</xref>
###xml 29 34 <span type="species:ncbi:9606">human</span>
###xml 105 110 <span type="species:ncbi:10090">mouse</span>
###xml 161 166 <span type="species:ncbi:10090">mouse</span>
###xml 412 418 <span type="species:ncbi:9986">rabbit</span>
###xml 480 485 <span type="species:ncbi:9940">sheep</span>
###xml 491 496 <span type="species:ncbi:10090">mouse</span>
###xml 500 504 <span type="species:ncbi:9925">goat</span>
###xml 510 516 <span type="species:ncbi:9986">rabbit</span>
###xml 551 556 <span type="species:ncbi:9940">sheep</span>
###xml 562 567 <span type="species:ncbi:10090">mouse</span>
###xml 572 576 <span type="species:ncbi:9925">goat</span>
###xml 582 588 <span type="species:ncbi:9986">rabbit</span>
Anti-C18 antibodies detected human DUF-959, Tsp-1C18 [8], FZC18 [7] and endostatin [54] as described and mouse DUF-959 (Saarela et al., unpublished). Monoclonal mouse antibodies were directed against: Hsc70, c-myc (9E10) and beta-catenin (E-5) (Santa Cruz); non phosphorylated beta-catenin (8E4 Upstate), myc and V5 tags (Invitrogen), penta-His tag (Qiagen) and glutamine synthetase (BD Biosciences). Polyclonal rabbit anti-cyclin D1 was from Labvision. Secondary antibodies were sheep anti-mouse or goat anti-rabbit coupled to peroxidase (Biorad) or sheep anti-mouse and goat anti-rabbit coupled to FITC or TRITC (Sigma), respectively. Immunoblots and immunohistochemistry were done as described [9]. Blot image files were processed with MultiGauge (FujiFilm Lifescience). Microscopes used: Olympus BX60 or confocal Leica TCS NT system on a Leica DMB microscope. Color digital files were prepared with Adobe RGB (1998) on Adobe Photoshop 7.
###end p 83
###begin p 84
###xml 25 30 <span type="species:ncbi:10090">mouse</span>
###xml 52 57 <span type="species:ncbi:10090">mouse</span>
###xml 156 161 <span type="species:ncbi:9940">sheep</span>
###xml 167 172 <span type="species:ncbi:10090">mouse</span>
For immunoprecipitation, mouse His-tagged Wnt3a and mouse V3Nter or V2Nter cDNAs were cotransfected in HEK 293-EBNA cells. Cell lysates were incubated with sheep-anti-mouse-IgG-coated Dynabeads M-280 (Dynal) conjugated with anti-His. After washing in RIPA buffer, complexes were eluted in denaturing sample buffer, resolved by 10% PAGE-SDS and immunoblotted with anti-His antibody (to detect Wnt3a) or with anti-DUF-959 (to detect V3Nter or V2Nter). To compete with the Wnt3a-V3Nter interaction, the synthetic peptide RH3 (AWGRFLHTNCHPFLA) from V3Nter CRD was added to culture media.
###end p 84
###begin title 85
Posttranslational modifications of C18
###end title 85
###begin p 86
###xml 41 44 41 44 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001878-Saarela1">[8]</xref>
###xml 960 964 956 960 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001878-Sasaki1">[23]</xref>
###xml 725 730 <span type="species:ncbi:9606">human</span>
Proteoglycans were purified as described [8]. Briefly, 900 mg from a frozen tumor was homogenized in 4M guanidine buffer, clarified by centrifugation and equilibrated in 8M urea buffer. Proteoglycans were isolated by batch anion-exchange on Q-Sepharose (GE Healthcare), followed by HiTrap-Q and eluted with NaCl (0.5M-1.5M). One microg of proteoglycan was digested in 4 mIU of heparin lyase II or III (Sigma), 120 mU of Chondroitinase ABC, (Seikagaku, Japan) or 20 U of collagenase (Worthington, USA). Proteins from mhAT3FS315 cells expressing V2Nter or V3Nter cDNAs were digested with N-glycosidase and Sialidase A (Glyko Enzymatic Deglycosylation kit, Prozyme). Heparin-binding proteins were isolated from 500 mg of frozen human HCC homogenized in non denaturing buffer with protease inhibitors (Sigma), clarified by ultracentrifugation and applied to a 5-ml HiTrap heparin column. After extensive washing, bound proteins were eluted stepwise (0.05-2M NaCl) [23].
###end p 86
###begin title 87
Colony formation assay and flow cytometry
###end title 87
###begin p 88
###xml 35 39 35 39 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001878-Suzuki1">[15]</xref>
###xml 252 254 252 254 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;1</sup>
###xml 272 274 272 274 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;1</sup>
Assays were performed as described [15]. Cells were transfected using Lipofectamine Plus (Invitrogen), stripped and plated in triplicates in 100-mm (colony formation) or 6-well plates (flow cytometry) 24 h after transfection and selected with 0.6 mg ml-1 G148 or 0.5 mg ml-1 zeocin (Invitrogen).
###end p 88
###begin title 89
Statistics
###end title 89
###begin p 90
###xml 165 166 165 166 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">R</italic>
###xml 188 193 188 193 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Gamma</italic>
Differences between means were assessed by the Mann-Whitney's "U" test. Bivariate relationships were calculated by the Spearman's rank-order correlation coefficient R or Goodman-Kruskal's Gamma (Statistica 7.1, StatSoft 2007).
###end p 90
###begin title 91
Supporting Information
###end title 91
###begin p 92
###xml 490 495 487 492 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">green</italic>
###xml 537 543 534 540 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">arrows</italic>
###xml 657 663 654 660 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">arrows</italic>
###xml 711 712 708 709 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">v</italic>
###xml 739 740 736 737 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">N</italic>
###xml 816 821 813 818 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">arrow</italic>
###xml 850 859 847 856 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">arrowhead</italic>
###xml 1059 1074 1053 1068 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SUPER8XTOPFLASH</italic>
###xml 1142 1157 1136 1151 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SUPER8XFOPFLASH</italic>
###xml 1403 1418 1394 1409 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SUPER8XTOPFLASH</italic>
###xml 1631 1632 1619 1620 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 1647 1648 1635 1636 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">t</italic>
###xml 1744 1750 1732 1738 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">VECTOR</italic>
###xml 1753 1755 1741 1743 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NS</italic>
###xml 1778 1782 1766 1770 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Left</italic>
###xml 1835 1843 1823 1831 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001878-g008">Figure 8</xref>
###xml 1856 1865 1844 1853 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0001878.s004">Figure S4</xref>
###xml 1969 1974 1957 1962 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Right</italic>
###xml 2889 2890 2873 2874 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 2905 2906 2889 2890 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">t</italic>
###xml 3002 3008 2986 2992 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">VECTOR</italic>
###xml 3011 3013 2995 2997 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NS</italic>
###xml 466 471 <span type="species:ncbi:10090">mouse</span>
###xml 1423 1428 <span type="species:ncbi:9606">human</span>
###xml 1808 1813 <span type="species:ncbi:9606">human</span>
###xml 2267 2272 <span type="species:ncbi:10090">mouse</span>
V3FL localizes at the cell surface, but does not inhibit Wnt/ beta-catenin signaling. (A) Schematic of V2FL and V3FL showing DUF-959, FZC18, Tsp-1C18 (thrombospondin-1) and ES (endostatin) modules. Thick horizontal lines indicate the antibodies used. (B-D) Overlays of immunofluorescence and phase contrast confocal microscopy of mhAT3FS315 hepatoma cells transiently transfected with V3FL (B) or V2FL (C and D) cDNAs and probed with anti-Tsp-1C18, followed by anti-mouse FITC-labeled IgG (green). V3FL highlights the cell membranes (B, arrows). V2FL is detected within the cell (C); by contrast, cell membranes and intercellular boundaries show no signal (arrows). V2FL (D) is detected within a large vacuole (v) indented by the nucleus (N) resembling a Golgi structure. The cell surface shows a secretion vesicle (arrow) and fraying-like material (arrowhead) suggesting secretion of V2. (E) Changes in CRT in response to increasing amounts of transiently transfected cDNA vectors. Reporter gene assays using a beta-catenin-TCF reporter driven by wild-type (SUPER8XTOPFLASH, white bars) or a negative control with mutated TCF binding sites (SUPER8XFOPFLASH, black bars). Results are means of three replicates from a representative experiment. Three independent experiments were performed. Error bars represent standard deviations. (F) Reporter gene assays using a beta-catenin-TCF responsive reporter (SUPER8XTOPFLASH) in human HCC Huh-7 cells (wild-type beta-catenin). Results are means of three replicates from a representative experiment. Three independent experiments were performed. Error bars represent standard deviations. P = (Student's "t" test) indicates statistical significance with respect to cells transfected with vector alone (VECTOR). NS, not significant. (G) Left: Protein extracts from a human HCC (case TL 06, see Figure 8, B, D-G and Figure S4, D and E) were chromatographed through Q-Sepharose and eluted with 0.5M (lane 1) and 1M (lane 2) NaCl. Right: One microg from the 1M NaCl fraction was incubated with the indicated enzymes. Protein samples were resolved by denaturing 5% PAGE-SDS and immunoblotted. Heparinase digestion results in mobility shift and epitope unmasking. (H) V2FL and V3FL cDNAs were transiently transfected in mhAT3FS315 mouse hepatoma cells. Protein samples from cell layers and from conditioned media were resolved by denaturing 5% PAGE-SDS and immunoblotted. Both V2FL and V3FL show a smear-like migration profile typical of proteoglycans. V2FL is soluble in conditioned medium. V3FL is detected at high levels in cell layers but is not detected in conditioned medium. (I) Reporter gene assays using cyclin D1 promoter reporter upstream luciferase cDNA in HCT116 and HepG2 cells. Results are means of three replicates from a representative experiment. Three independent experiments were performed. Error bars represent standard deviations. P = (Student's "t" test) indicates statistical significance with respect to cells transfected with vector alone (VECTOR). NS, not significant.
###end p 92
###begin p 93
(4.22 MB TIF)
###end p 93
###begin p 94
Click here for additional data file.
###end p 94
###begin p 95
###xml 82 86 82 86 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">left</italic>
###xml 99 104 99 104 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">right</italic>
###xml 536 539 524 527 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">myc</italic>
Sialylation of V3Nter resides within the DUF-959 module. (A) Schematic of V2Nter (left) and FZC18 (right) cDNA vectors and antibodies. Horizontal color lines below each module denote the antibodies used. (B) Immunoblot of mhAT3FS315 cell conditioned medium after transfection with FZC18 cDNA. Proteins were separated in denaturing 7.5% PAGE-SDS. The asterisk (*) denotes immunoglobulins from FCS-containing medium. N-glycosidase digestion induces a approximately3kD mobility shift of the FZC18 module detected by anti-FZC18 and by anti-myc tag antibodies. (C) N-glycosidase and Sialidase A digestion of V2Nter. Protein extracts from cell layers were incubated at 37 {degree sign}C for 2 hr with N-glycosidase and Sialidase A or with buffer alone. Sialidase A reveals polypeptides of approximately30 kD and 32 kD.
###end p 95
###begin p 96
(0.76 MB TIF)
###end p 96
###begin p 97
Click here for additional data file.
###end p 97
###begin p 98
###xml 255 257 251 253 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;1</sup>
###xml 398 400 394 396 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IP</italic>
###xml 960 964 950 954 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001878-Dann1">[25]</xref>
###xml 1078 1083 1068 1073 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Phyre</italic>
###xml 149 154 <span type="species:ncbi:10090">mouse</span>
###xml 182 187 <span type="species:ncbi:10090">mouse</span>
A 15-amino acid peptide derived from the CRD of FZC18 (RH3 peptide) competes with FZC18 binding to Wnt3a. (A) EBNA-293 cells were cotransfected with mouse V3Nter and with His-tagged mouse Wnt3a. Transfected cells were incubated with 0; 50 or 100 microgxml-1 of the synthetic peptide RH3 from the CRD domain of FZC18. Cell lysates were analyzed by immunoblot (10% PAGE-SDS) or coimmunoprecipitated (IP) with monoclonal anti-His antibody. (B) 3D structure prediction of the FZC18 CRD and modeling of the potential surfaces involved in Wnt-FZC18 interactions. SFRP3 and Frizzled-8 CRD crystal structures were used as templates. The orientation of the CRD surface on the right is rotated 180degrees about the vertical axis with respect to left-side images. Blue, N-termini; gray, C-termini; green, surfaces involved in Wnt-CRD interactions inferred from structure-based alignment of FZC18, SFRP3 and FZ8 CRDs and from described mutations affecting Wnt-CRD binding [25]. Red, localization of the RH3 peptide. Yellow, red and green overlay. 3D structure prediction was done using the Phyre www server and Protein Explorer 2.79.
###end p 98
###begin p 99
(1.74 MB TIF)
###end p 99
###begin p 100
Click here for additional data file.
###end p 100
###begin p 101
###xml 66 71 66 71 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">brown</italic>
###xml 155 157 155 157 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PT</italic>
###xml 184 185 184 185 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">v</italic>
###xml 222 227 222 227 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">arrow</italic>
###xml 273 282 273 282 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001878-g008">Figure 8B</xref>
###xml 313 319 313 319 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">arrows</italic>
###xml 415 424 415 424 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001878-g008">Figure 8B</xref>
###xml 488 489 488 489 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">H</italic>
###xml 536 537 536 537 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">S</italic>
###xml 571 579 571 579 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001878-g008">Figure 8</xref>
###xml 692 698 692 698 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">arrows</italic>
###xml 761 771 761 771 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">arrowheads</italic>
###xml 861 862 861 862 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">s</italic>
###xml 22 27 <span type="species:ncbi:9606">human</span>
###xml 83 88 <span type="species:ncbi:9606">human</span>
Detection of FZC18 in human liver. (A) Immunoperoxidase staining (brown) in normal human liver shows FZC18 in periportal hepatocytes. In the portal tract (PT), including portal veins (v), bile ducts and basement membrane (arrow) no signal is detected. Case NL 04, shown in Figure 8B. (B) HCC. Speckle-like FZC18 (arrows) is seen on the surface of tumor cells highlighting intercellular spaces (case TL 03, shown in Figure 8B). (C) Liver cirrhosis shows speckle-like FZC18 in hepatocytes (H). No FZC18 is seen in the surrounding stroma (S). (D and E) Case TL 06, shown in Figure 8, B and D-G. Contrasting topology of FZC18 (D) and DUF-959 (E) in HCC. FZC18 highlights the pericellular matrix (arrows) and is also detected as supranuclear intracellular material (arrowheads). In the same tumor, DUF-959 outlines cords of tumor cells highlighting tumor sinusoids (s).
###end p 101
###begin p 102
(9.05 MB TIF)
###end p 102
###begin p 103
Click here for additional data file.
###end p 103
###begin p 104
###xml 41 49 41 49 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 237 240 237 240 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">red</italic>
###xml 98 103 <span type="species:ncbi:10090">mouse</span>
###xml 211 217 <span type="species:ncbi:9986">rabbit</span>
3D cell surface reconstruction of V3Nter in vitro. Confocal fluorescence microscopy of mhAT3FS315 mouse liver cancer cells transiently transfected with V3Nter cDNA and probed with anti-DUF-959, followed by anti-rabbit TRITC-labeled IgG (red). Original magnificationx1000. Fifteen representative images acquired at 500-nm intervals on the vertical axis were stacked on ImageJ 1.37v (NIH, USA).
###end p 104
###begin p 105
(0.13 MB MOV)
###end p 105
###begin p 106
Click here for additional data file.
###end p 106
###begin p 107
###xml 40 47 40 47 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 160 176 160 176 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001878-g008">Figures 8B and S</xref>
###xml 316 325 316 325 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001878-g008">Figure 8B</xref>
###xml 107 112 <span type="species:ncbi:9606">human</span>
3D cell surface reconstruction of FZC18 in vivo. Reconstruction of FZC18 staining at the cell surface in a human hepatocellular carcinoma (case TL 03, shown in Figures 8B and S4B). Original magnificationx1000. Images were acquired on the vertical axis and stacked on ImageJ 1.37v (NIH, USA). In the light of data on Figure 8B, cell surface signal shows proteolyzed FZC18-containing V3C18 polypeptides.
###end p 107
###begin p 108
(0.13 MB MOV)
###end p 108
###begin p 109
Click here for additional data file.
###end p 109
###begin p 110
###xml 132 138 <span type="species:ncbi:8164">Suzuki</span>
We thank S. Bayling, P. Bioulac-Sage, K. Boudjema, J.P. Campion, R. Grosschedl, J. Kitajewski, R. Moon, R. Nusse, J. Pouyssegur, H. Suzuki and B. Turlin for providing reagents or tissue samples; R. Primault, E. Robert and N. Theret for technical help; B. Pitre and A. Vannier for secretarial work and A. Corlu and A. Guillouzo for critical reading of the manuscript.
###end p 110
###begin title 111
References
###end title 111
###begin article-title 112
Matricellular proteins: extracellular modulators of cell function.
###end article-title 112
###begin article-title 113
Alpha 1(XVIII), a collagen chain with frequent interruptions in the collagenous sequence, a distinct tissue distribution, and homology with type XV collagen.
###end article-title 113
###begin article-title 114
###xml 0 5 <span type="species:ncbi:10090">Mouse</span>
Mouse Col18a1 is expressed in a tissue-specific manner as three alternative variants and is localized in basement membrane zones.
###end article-title 114
###begin article-title 115
Endostatin: an endogenous inhibitor of angiogenesis and tumor growth.
###end article-title 115
###begin article-title 116
###xml 24 29 <span type="species:ncbi:10090">mouse</span>
Characterization of the mouse gene for the alpha 1 chain of type XVIII collagen (Col18a1) reveals that the three variant N-terminal polypeptide forms are transcribed from two widely separated promoters.
###end article-title 116
###begin article-title 117
The promoter of the long variant of collagen XVIII, the precursor of endostatin, contains liver-specific regulatory elements.
###end article-title 117
###begin article-title 118
###xml 24 29 <span type="species:ncbi:9606">human</span>
Characterization of the human type XVIII collagen gene and proteolytic processing and tissue location of the variant containing a frizzled motif.
###end article-title 118
###begin article-title 119
###xml 143 149 <span type="species:ncbi:9606">humans</span>
The short and long forms of type XVIII collagen show clear tissue specificities in their expression and location in basement membrane zones in humans.
###end article-title 119
###begin article-title 120
###xml 143 148 <span type="species:ncbi:9606">human</span>
Tumor hepatocytes and basement membrane producing cells specifically express two different forms of the endostatin precursor collagen XVIII in human liver cancers.
###end article-title 120
###begin article-title 121
###xml 124 129 <span type="species:ncbi:9606">human</span>
Tumor progression is associated with a significant decrease in the expression of the endostatin precursor collagen XVIII in human hepatocellular carcinomas.
###end article-title 121
###begin article-title 122
The Frizzled CRD domain is conserved in diverse proteins including several receptor tyrosine kinases.
###end article-title 122
###begin article-title 123
Wnt/beta-catenin signaling in development and disease.
###end article-title 123
###begin article-title 124
###xml 54 59 <span type="species:ncbi:10090">mouse</span>
Apc tumor suppressor gene is the "zonation-keeper" of mouse liver.
###end article-title 124
###begin article-title 125
The Wnt antagonist sFRP1 in colorectal tumorigenesis.
###end article-title 125
###begin article-title 126
Epigenetic inactivation of SFRP genes allows constitutive WNT signaling in colorectal cancer.
###end article-title 126
###begin article-title 127
Genetics of hepatocellular tumors.
###end article-title 127
###begin article-title 128
Promoter methylation of the secreted frizzled-related protein 1 gene SFRP1 is frequent in hepatocellular carcinoma.
###end article-title 128
###begin article-title 129
Overproduction of a truncated hepatocyte nuclear factor 3 protein inhibits expression of liver-specific genes in hepatoma cells.
###end article-title 129
###begin article-title 130
###xml 139 144 <span type="species:ncbi:9606">human</span>
Collagen XVIII is localized in sinusoids and basement membrane zones and expressed by hepatocytes and activated stellate cells in fibrotic human liver.
###end article-title 130
###begin article-title 131
###xml 59 64 <span type="species:ncbi:10090">mouse</span>
###xml 69 74 <span type="species:ncbi:9606">human</span>
Somatic mutations of the beta-catenin gene are frequent in mouse and human hepatocellular carcinomas.
###end article-title 131
###begin article-title 132
Wnts as ligands: processing, secretion and reception.
###end article-title 132
###begin article-title 133
Cyclin D1 expression is regulated positively by the p42/p44MAPK and negatively by the p38/HOGMAPK pathway.
###end article-title 133
###begin article-title 134
Structure, function and tissue forms of the C-terminal globular domain of collagen XVIII containing the angiogenesis inhibitor endostatin.
###end article-title 134
###begin article-title 135
###xml 127 130 <span type="species:ncbi:10116">rat</span>
Studies on plasma membranes. IV. The ultrastructural localization and content of sialic acid in plasma membranes isolated from rat liver and hepatoma.
###end article-title 135
###begin article-title 136
Insights into Wnt binding and signalling from the structures of two Frizzled cysteine-rich domains.
###end article-title 136
###begin article-title 137
###xml 82 87 <span type="species:ncbi:9606">human</span>
Differential effects of inactivated Axin1 and activated beta-catenin mutations in human hepatocellular carcinomas.
###end article-title 137
###begin article-title 138
###xml 208 211 <span type="species:ncbi:10116">rat</span>
###xml 216 226 <span type="species:ncbi:7227">Drosophila</span>
Identification of three N-terminal ends of type XVIII collagen chains and tissue-specific differences in the expression of the corresponding transcripts. The longest form contains a novel motif homologous to rat and Drosophila frizzled proteins.
###end article-title 138
###begin article-title 139
###xml 66 71 <span type="species:ncbi:9606">human</span>
An autocrine mechanism for constitutive Wnt pathway activation in human cancer cells.
###end article-title 139
###begin article-title 140
SARPs: a family of secreted apoptosis-related proteins.
###end article-title 140
###begin article-title 141
###xml 86 91 <span type="species:ncbi:9606">human</span>
Expression of Frzb/secreted Frizzled-related protein 3, a secreted Wnt antagonist, in human androgen-independent prostate cancer PC-3 cells suppresses tumor growth and cellular invasiveness.
###end article-title 141
###begin article-title 142
Wnt-1 signaling inhibits apoptosis by activating beta-catenin/T cell factor-mediated transcription.
###end article-title 142
###begin article-title 143
Exogenous expression of beta-catenin regulates contact inhibition, anchorage-independent growth, anoikis, and radiation-induced cell cycle arrest.
###end article-title 143
###begin article-title 144
###xml 49 54 <span type="species:ncbi:9606">human</span>
Blockade of Wnt-1 signaling induces apoptosis in human colorectal cancer cells containing downstream mutations.
###end article-title 144
###begin article-title 145
Inhibition of Wnt-2-mediated signaling induces programmed cell death in non-small-cell lung cancer cells.
###end article-title 145
###begin article-title 146
Specific inhibition of gene expression using a stably integrated, inducible small-interfering-RNA vector.
###end article-title 146
###begin article-title 147
###xml 59 64 <span type="species:ncbi:9606">human</span>
WNTS and WNT receptors as therapeutic tools and targets in human disease processes.
###end article-title 147
###begin article-title 148
Wnt signaling promotes oncogenic transformation by inhibiting c-Myc-induced apoptosis.
###end article-title 148
###begin article-title 149
Cell cycle regulation and apoptosis.
###end article-title 149
###begin article-title 150
Identification of c-MYC as a target of the APC pathway.
###end article-title 150
###begin article-title 151
###xml 48 53 <span type="species:ncbi:9606">human</span>
Beta-catenin accumulation in the progression of human hepatocarcinogenesis correlates with loss of E-cadherin and accumulation of p53, but not with expression of conventional WNT-1 target genes.
###end article-title 151
###begin article-title 152
###xml 36 40 <span type="species:ncbi:10090">mice</span>
Liver-targeted disruption of Apc in mice activates beta-catenin signaling and leads to hepatocellular carcinomas.
###end article-title 152
###begin article-title 153
Beta-catenin regulates expression of cyclin D1 in colon carcinoma cells.
###end article-title 153
###begin article-title 154
The soluble wnt receptor Frizzled8CRD-hFc inhibits the growth of teratocarcinomas in vivo.
###end article-title 154
###begin article-title 155
Interaction of frizzled related protein (FRP) with Wnt ligands and the frizzled receptor suggests alternative mechanisms for FRP inhibition of Wnt signaling.
###end article-title 155
###begin article-title 156
###xml 84 89 <span type="species:ncbi:10090">mouse</span>
Overexpression of glutamine synthetase is associated with beta-catenin-mutations in mouse liver tumors during promotion of hepatocarcinogenesis by phenobarbital.
###end article-title 156
###begin article-title 157
Mitochondrial metabolism of glutamine and glutamate and its physiological significance.
###end article-title 157
###begin article-title 158
In search of partners: linking extracellular proteases to substrates.
###end article-title 158
###begin article-title 159
Helping Wingless take flight: how WNT proteins are secreted.
###end article-title 159
###begin article-title 160
###xml 0 5 <span type="species:ncbi:9606">Human</span>
Human bradykinin B2 receptor sialylation and N-glycosylation participate with disulfide bonding in surface receptor dimerization.
###end article-title 160
###begin article-title 161
###xml 15 20 <span type="species:ncbi:9606">human</span>
###xml 43 60 <span type="species:ncbi:10407">hepatitis B virus</span>
Infection of a human hepatoma cell line by hepatitis B virus.
###end article-title 161
###begin article-title 162
###xml 47 64 <span type="species:ncbi:10407">hepatitis B virus</span>
###xml 95 100 <span type="species:ncbi:9606">human</span>
trans-Acting factors, detoxication enzymes and hepatitis B virus replication in a novel set of human hepatoma cell lines.
###end article-title 162
###begin article-title 163
###xml 0 9 <span type="species:ncbi:7955">Zebrafish</span>
Zebrafish prickle, a modulator of noncanonical Wnt/Fz signaling, regulates gastrulation movements.
###end article-title 163
###begin article-title 164
Modulation of transcriptional regulation by LEF-1 in response to Wnt-1 signaling and association with beta-catenin.
###end article-title 164
###begin article-title 165
Interaction of endostatin with integrins implicated in angiogenesis.
###end article-title 165
###begin p 166
###xml 0 21 0 21 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Competing Interests: </bold>
Competing Interests: The authors have declared that no competing interests exist.
###end p 166
###begin p 167
###xml 0 9 0 9 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Funding: </bold>
Funding: Inserm, Universite de Rennes 1, ARC #5158, Region Bretagne, INCA 2007 and Finnish Centre of Excellence Program of Academy of Finland #44843
###end p 167

